ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0000211.1|Chrysomycin_1 # 1 # 561 # -1 # ID=1_1;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.658	BGC0000211.1|Chrysomycin_1 	1	561	-	Loose	400	25.0238	vanRD	27.5	3002923	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	TTGACTGTCCATCAGCTGCGCAGCGTCTCCCGATCCGAGCACAACCTTCTGGATGAGTCGTGGGTCACATTGGGCAGGAGCAACCGCCTCGAAGAGTTGCAAGGGGGAAATATGAGATTCAGCCGTTCCGTCCTGGCTGCCTCCGCCGTAGCGGCCCTGGCCATGGGGGCCACGACCGCCCTGGCGGCGCCGGCCTCCGCCGCGCCCAACACCACCCCGCAGAAGGTCTGCGGAAGCGGCTACAAGACCGTGAACTCGGTGCCCGTCGGATCGCAGGGGACCGTCTACCTGACGTACAACTCGACCAACGGCAAGAACTGCGTCGCGACCATCCGCACCAACCCGGGCACCGCCCGGGACATGTCCGCGTGGATCTACGTCCCCGACACCGACGCGTACGACCAGGACTACGGGACGTACACGTCGTACGCGGGACCGACCTACGTCTACGGCAAGGCCCACTGCGTCGACTGGGGCGGCAGCATCGGCAACGTGTACGTGGAGGTGTACGGCTCCAACTGTGCCGCGCTGAGGGAGCACCGGGTCACCTACACCCGCTGA	MTVHQLRSVSRSEHNLLDESWVTLGRSNRLEELQGGNMRFSRSVLAASAVAALAMGATTALAAPASAAPNTTPQKVCGSGYKTVNSVPVGSQGTVYLTYNSTNGKNCVATIRTNPGTARDMSAWIYVPDTDAYDQDYGTYTSYAGPTYVYGKAHCVDWGGSIGNVYVEVYGSNCAALREHRVTYTR	MNEKILVVDDEKELADLVEVYLKNDGYTVYKFYNGRDALNCIESVELDLAILDIMLPDIDGFQICQKIREKFYFPVIMLTAKVEDGDKIMGLSVADDYITKPFNPLEVVARVKAQLRQYMRYKQPCIKQEAERTEYDIRGMTISKSSHKCILFGKEIQLTPTEFSILWYLCERQGTVVSTEELFEAVWGERYFDSNNTVMAHIGRLREKMKEPSRNPKFIKTVWGVGYTIEK	80.17	gnl|BL_ORD_ID|949|hsp_num:0	1004		
BGC0000211.1|Chrysomycin_2 # 893 # 1678 # 1 # ID=1_2;partial=00;start_type=TTG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.705	BGC0000211.1|Chrysomycin_2 	893	1678	+	Loose	500	25.409	ErmD	26.92	3000495	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	TTGGCGAACGGTGCCGGAAAGACCGCTCTCATCACCGGAGCGACCAGTGGCATCGGCCTGGCCGTCGCACACCGGCTGGCCGAGTCCGGCTTCCGCGTCTTCCTGTGCGCCCGTGGCGCGGACGCCGTGAAGCGGACGGCCGGGCAGCTCCGGGCCGCGGGCCACGAAGCGGACGGCGTCGCCTGCGACGTCCGCTCGGCGGAGCGGATACGGGCGATGGTGACCGAGGCGGCCGAGCGCTACGGCAGCATCGACGTCCTCGTCAACAACGCGGGCACCGGTGGCGGCGGCGTCACCGCGGACCTCACCGACGAGGCGTGGGCCGACGTCATCGACACGAACCTCAACAGCGTCTTCCACGTCACGCGCGACGTGCTCTCGATGGGCCGGATGCGCGACAAGAGCTGGGGACGCATCGTCAACATCGCCTCGACCGCGGGGAAGCAGGGCGTGGTCCTCGCCGCCCCGTACTCGGCGTCCAAGCACGGGGTCGTCGGATTCACCAAGTCCCTCGGGAACGAGCTGGCGAAGACCGGCATCACCGTGAACGCGGTCTGCCCGGGATACGTGGAGACGCCGATGGCGGAGCGTGTGCGCAGCGGCTACGCCCGGGCGTGGGAGACGACCGAGGAGGACATCCTCCAGCGGTTCGAGGCGAAGATCCCGCTGGGCCGCTACTCGACCGTCACCGAGGTGGCGGGCATGGTCGGCTACCTCGTCAGCGACACCGCCGCCTCGGTGACCTCGCAGGCCATCAACGTGTGCGGCGGCCTCGGCAACTTCTGA	MANGAGKTALITGATSGIGLAVAHRLAESGFRVFLCARGADAVKRTAGQLRAAGHEADGVACDVRSAERIRAMVTEAAERYGSIDVLVNNAGTGGGGVTADLTDEAWADVIDTNLNSVFHVTRDVLSMGRMRDKSWGRIVNIASTAGKQGVVLAAPYSASKHGVVGFTKSLGNELAKTGITVNAVCPGYVETPMAERVRSGYARAWETTEEDILQRFEAKIPLGRYSTVTEVAGMVGYLVSDTAASVTSQAINVCGGLGNF	MKKKNHKYRGKKLNRGESPNFSGQHLMHNKKLIEEIVDRANISIDDTVLELGAGKGALTTVLSQKAGKVLAVENDSKFVDILTRKTAQHSNTKIIHQDIMKIHLPKEKFVVVSNIPYAITTPIMKMLLNNPASGFQKGIIVMEKGAAKRFTSKFIKNSYVLAWRMWFDIGIVREISKEHFSPPPKVDSAMVRITRKKDAPLSHKHYIAFRGLAEYALKEPNIPLCVRLRGIFTPRQMKHLRKSLKINNEKTVGTLTENQWAVIFNTMTQYVMHHKWPRANKRKPGEI	90.94	gnl|BL_ORD_ID|1049|hsp_num:0	1117		
BGC0000211.1|Chrysomycin_3 # 1821 # 2153 # 1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=8bp;gc_cont=0.637	BGC0000211.1|Chrysomycin_3 	1821	2153	+	Loose	650	22.7126	vanL	30.77	3002910	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; van ligase	GTGAAGTACACCGCGTTCCTCGGCGTCCGCTTCGAACCCGAATGGTTCCTCATGGACCGGGACGAGCGGGAGAAATTCGAGTCCGAACACGTCTTCCCGATCCTCGCGAAGCACGCGCGGTTCCTGGAGATCCGGCCCTTCCGGGCCTCGGCCTTCAGCTCCCGGCACACGAACTTCTTCCTCGTCCACTTCGACGACATCCCCGCGTACAACAGCCTCATCGAGGAGATGCGCGAACGTCCGCTGCTGGCCAACCGGTTCGCCACCATCACGGACAACTTCATCGGCATCGAGGCCGCCCACTACACGGACGACGAGGAGACGGCGGCCTGA	MKYTAFLGVRFEPEWFLMDRDEREKFESEHVFPILAKHARFLEIRPFRASAFSSRHTNFFLVHFDDIPAYNSLIEEMRERPLLANRFATITDNFIGIEAAHYTDDEETAA	MMKLKKIAIIFGGQSSEYEVSLKSTVSVLETLSTCNFEIIKIGIDLGGKWYLTTSNNKDIEYDVWQTDPSLQEIIPCFNNRGFYNKTTNKYFRPDVLFPILHGGTGEDGTLQGVFELMNIPYVGCGVTPSAICMDKYLLHEFAQSVGVKSAPTLIIRTRNCKDEIDKFIEKNDFPIFVKPNEAGSSKGINKVNEPDKLEDALTEAFKYSKSVIIQKAIIGREIGCAVLGNEKLLVGECDEVSLNSDFFDYTEKYQMISAKVNIPASISVEFSNEMKKQAQLLYRLLGCSGLARIDFFLSDNNEILLNEINTLPGFTEHSRYPKMMEAVGVTYKEIITKLINLAEEKYYG	31.52	gnl|BL_ORD_ID|325|hsp_num:0	349		
BGC0000211.1|Chrysomycin_4 # 2228 # 2797 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.707	BGC0000211.1|Chrysomycin_4 	2228	2797	+	Loose	600	25.409	vanHB	30.0	3002943	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATGTCCACCATCGGAATCATCCTGGGCAGCAGCCGGCCGGGAAGGCAGGGCGAAGCGGTCGCCCGGTGGGTCCACGGCATCGCGGACGAACGCGACGACGCCGCCTTCGAGTTCATCGACCTCGCCGAGGTCGCCCTGCCCCACTTCGACGAGGCGATTCCCCCCATGGCGGGTGCGTACGCGCAGCCGCACACCCTCGCCTGGGCGGAACGGATCGCCCGCCTCGACGGCTTCGTCTTCGTCACTCCCGAGTACAACAACTCCGTGCCCGGCGTGCTGAAGAACGCCGTCGACTTCCTGTTCGCCGAATGGGGGAACAAGGCGGCGGGCTTCGTGGGGTACGGGCCGACCGGGGCCATCCGCGCCGTCGAGCATCTGCGCCTGATCATGTCGGAGCTCCAGGTCGCCACCGTGCGCGCCCAGGCGGCCCTGACCTTCGCCACGGACTTCGCCGACCGCACCACGTTCCGGCCCGCCCCGGAGAGCCGGGCGGTCGTCGACCAGATCCTGGACCAGGTCGTCTCCTGGTCCCAGGCGCTGGAGCCGGTCCGCCGCAAGGCGCGGGCATGA	MSTIGIILGSSRPGRQGEAVARWVHGIADERDDAAFEFIDLAEVALPHFDEAIPPMAGAYAQPHTLAWAERIARLDGFVFVTPEYNNSVPGVLKNAVDFLFAEWGNKAAGFVGYGPTGAIRAVEHLRLIMSELQVATVRAQAALTFATDFADRTTFRPAPESRAVVDQILDQVVSWSQALEPVRRKARA	MRKSMGITVFGCEQDEANAFRTLSPDFHIIPTLISDAISADNAKLAAGNQCISVGHKSEVSEATILALRKVGVKYISTRSIGCNHIDTTAAERMGISVGTVAYSPDSVADYALMLMLMAIRGAKSTIHAVAQQNFRLDCVRGKELRDMTVGVIGTGHIGQAVVKRLRGFGCRVLAYDNSRKIEADYVQLDELLKNSDIVTLHVPLCADTRHLIGQSEIGEMKQGAFLINTGRGALVDTGSLVEALGSGKLGGAALDVLEGEDQFVYTDCSQKVLDHPFLSQLLRMPNVIITPHTAYYTERVLRDTTEKTIRNCLNFERSLQHE	58.51	gnl|BL_ORD_ID|586|hsp_num:0	626		
BGC0000211.1|Chrysomycin_5 # 2794 # 4335 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.752	BGC0000211.1|Chrysomycin_5 	2794	4335	+	Loose	900	259.996	iri	39.24	3002884	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGACGGGGACGGGCACCGGCCCCGGGCCCGGTGCGGCGGCGCCGGACGCACGGCTGGACGCGCCGGTCGTCGTGGCCGGCGCGGGACCCACCGGACTGATGCTGGCCGGTGAACTCCGCCTCGGCGGCGTGGAGGTGATCGTCCTCGACCGGCTGACCGAGCCGGTCACCGAGTCCCGCGGACTCGGCTTCACCGCCCGGGCCACCGAGGTCTTCGACCAGCGGGGCCTGCTGGACCGCTTCGCGAACCCCGAGATCAGCCCACGGGGCCACTTCGGCGGCATCCCGATGGACTACGACGTCCTGCCCGGCGGGCACTTCGGCGTACGCAACGTCGAACAGACCGAGACCGAGCGCGTGTTGAGAGAGTGGGCCACCGGACTCGGGGCCGGTGTCCGGCCCGGCCACGAGGTCACCGGCGTACGGCAGTCCGGGGAGCGGGTCGAGGTCGAGGTGTCCGGCCCCCGGGGCGAGGAGGTGCTGCGCTGCTCCTACCTGGTCGGCGCGGACGGCGGGCGCAGCACCGTGCGGCGGGCCGCGGGCTTCGACTTCCCCGGGCACGACGCGACCTGCGAGATGTTCCTGGCCGACGTCGCGGGCGTCGGCATCCGCCCGCGGTTCCTCGGTGAACGGGTTCCCGGCGGCATGGTGATGGCCGCCCGGCTGAGCGACGACGTGGACCGCGTCATCGTCTGCGAACGCGGTACCGCGCCCGAGGAGCGCACCGCGCCGCCCGCCTTCCAGGAGATCGCCGGTGCGTGGCGGCGGCTCACCGGTGAGGACATAAGCCACGGCGAGGCCCGCTGGACCAGTTCCTTCACCGACGCCGCGCGGCTCGTCACCGAGTACCGCCGCGGACGCGTGTTCCTGGCCGGGGACGCCGCCCACATCCATCTGCCGGCGAGCGGCCAGGGCCTCAGCGTCGGTGTGCAGGACGCGGTGAACCTGGGCTGGAAGCTCGCGGCCGTCGTCGGCGGCCACAGCGACGAGAGCCTGCTCGACACCTACCACCGGGAACGCCACCCCGTGGGCGAGCGCGTCCTGACCAACACCCGGGCCCAGGGCCTCCTCTACCTCGGCGGCAGCGAGGTGGAACCGCTGCGCGCGGTGCTCGGCGAACTGCTGGACGACCCCGGGGTGGCCCGCCGTCTGGCCGGGATGGTCAGCGGCCTCGACATCCGCTGTCCCGTCGGCCCCGGCACCCACCCCCTGCTCGGGCTGCGGATGCCCCCCTGCGACCTGCTCGTCGGCGCGGACGCCACCACCTCGGCGTGTCTGCTGCGTGCCGGGCGGGGCGTACTCCTCCAGCTCGACGACGACCCCGGCCCGGCCCGGACCGCCGCACCGTGGGCGGGCCGCGTCGACGTCGTGCAGGCGGTCTGCGCCGACGAACGACTCGCCGGTACACGTGCCGTACTGCTGCGCCCCGACGGCCACATCGCCTGGGCGGCGCCCGACGGAGGGGACCTGGCCGAAGCGCTCGGCACCTGGTTCGGGGCCGCCGGCCGCGTCCGGCGGGCGGTGACCGCGGCACACCGGTGA	MTGTGTGPGPGAAAPDARLDAPVVVAGAGPTGLMLAGELRLGGVEVIVLDRLTEPVTESRGLGFTARATEVFDQRGLLDRFANPEISPRGHFGGIPMDYDVLPGGHFGVRNVEQTETERVLREWATGLGAGVRPGHEVTGVRQSGERVEVEVSGPRGEEVLRCSYLVGADGGRSTVRRAAGFDFPGHDATCEMFLADVAGVGIRPRFLGERVPGGMVMAARLSDDVDRVIVCERGTAPEERTAPPAFQEIAGAWRRLTGEDISHGEARWTSSFTDAARLVTEYRRGRVFLAGDAAHIHLPASGQGLSVGVQDAVNLGWKLAAVVGGHSDESLLDTYHRERHPVGERVLTNTRAQGLLYLGGSEVEPLRAVLGELLDDPGVARRLAGMVSGLDIRCPVGPGTHPLLGLRMPPCDLLVGADATTSACLLRAGRGVLLQLDDDPGPARTAAPWAGRVDVVQAVCADERLAGTRAVLLRPDGHIAWAAPDGGDLAEALGTWFGAAGRVRRAVTAAHR	MSDVIIVGAGPTGLMLAGELRLQGVDVVVVDKDEEPTQFVRALGIHVRSIEIMEQRGLLDKFLAHGRKYPLGGFFAGISKPAPAHLDTAHGYVLGIPQPEIDRILAEHATEVGADIQRGKRVVAIRQDTDNVAAELSDGTTLHARYLVGCDGGRSTVRKLRSTSVFPASRTSADTLIGEMDVTMPADELAAVVAEIRETHKRFGVGPAGNGAFRVVVPAAEVADGRATPTTLDDIKQQLLAIAGTDFGVHSPRWLSRFGDATRLADDYRRDRVFLAGDAAHIHPPMGGQGLNLGVQDAFNLGWKLAAEINGWAPVGLLDTYESERRPVAADVLDNTRAQAELISTAAGPQAVRRLISELMEFEDVKRYLTEKITAISIRYDFGEGDDLLGRRLRNIALTRGNLYDLMRSGRGLLLDQGGQLSVDGWSDRADHIVDTSTELEAPAVLLRPDGHVAWIGDAQAELDTQLSTWFGRSARDRA	107.10	gnl|BL_ORD_ID|750|hsp_num:0	796		
BGC0000211.1|Chrysomycin_7 # 4760 # 5011 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5bp;gc_cont=0.702	BGC0000211.1|Chrysomycin_7 	4760	5011	+	Loose	1500	22.3274	rphA	26.76	3000444	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	ATGACCGTTGCCGTGTTCACCCTCGACGACCTCCGACGCATCCTGATCGGCGTGGCGGGCGCCGACGAGGACATCGACCTGGGCGGCGACAGCGCGGACACGCTGTTCACCGACCTCGGATACGACTCGCTCGCCCTGCTGGAGACCGCCGCGGCCGTCTCCCGGGAGTACGGCGTCACCCTCGACGACGAGGCCGTCACCGCCGTCACCACACCACGGGGCTTCGTCGGCCTGGTCAACGACGCCGCCTGA	MTVAVFTLDDLRRILIGVAGADEDIDLGGDSADTLFTDLGYDSLALLETAAAVSREYGVTLDDEAVTAVTTPRGFVGLVNDAA	MSGRLVVDLQDVDAAGLAEVGGKGAHLGELSRIDGVRVPSGFCVTTHAFRRIMAEAPESGELLDRLSRVDEGDQEAVRSLAARLRQVVGATPLPDEVAAAVTGALARHGERSAYAVRSSATAEDLPTASFAGQQDTYLNVVGTEEILRHVSRCWASLFTERAVTYRGRQGVDHRTVHMGVVVQRMVVPRASGILFTADPVTGDRRTATVDAGFGLGEALVSGLVDPDVLTVRHGEVVARTIAAKRRALHAVQGGGTRETPIEERRQREPVLTDDQAVELVALGRRIEAHFGSPQDIEWCLDDDGFHIVQSRPITTLFPVPERDDDVFRVYLSVGHQQMMTDAMKPLGLSMWRLTALAPMYEAGGRLFVDATARLAVPGSRATLLDVVGRGDPLTRDALETVLENGEFEPTPAETDGGAPPAGDGAEPDEADPSIVTELIERSRRSLAELEREIGTKSGPALFAFLREAFEEHKRVVGDPLNIRAIMAGMEATWWLNDRLEEWLGEKNAADTLTLSAPDNVTSEMGLELLDVADVVRTHPEVVAFLEGVEDDGFLDELPKVPGGAEARDAFEAYLDRYGMRCVGEIDITXPPVRERPSALVPVVLDHVRAFGPGAAARRFEDGRRRALAKEREVLERLRDLPDGERRADAARRMIRQVRAFAGYREYPKYAIVSRSFVYRQALLREADELVRAGVLADREDVHYLTFDEFEEAVRVRRVDERLVRRRKDAFRSYQALTPPRVLTSEGVALSGAYRRDDVPEGALAGLAVSAGTVEGRARVVLDMAEADLEAGDILVTRFTDPSWSPLFVGIAGLVTEVGGLMTHGAVIAREYGLAAVVGVERATRLIRDGQRIRVHGTEGYIELLS	9.60	gnl|BL_ORD_ID|911|hsp_num:0	910		
BGC0000211.1|Chrysomycin_8 # 5072 # 6016 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.716	BGC0000211.1|Chrysomycin_8 	5072	6016	+	Loose	600	28.1054	OprZ	43.75	3004142	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCCGGACCGAAGGTCCACGAAGCCGAGCACCACATCACCGTCGCCGCGTCCGCGAAGGCCGTCCACCAGCTTCTCGTCGAGGTGGAGAACTGGCCGCTGCTGTTCCCGCCGAGCGTGCACGTGGAACGCCTCGAACAGGACGGTGAGCACGAACGGATACGGATCTGGGCCACCGCCAACGGCGCGGCCAAGACCTGGACGTCCCGCAGGCGTATCGACGCCGCCGAAGGCCGGATCGAGTTCCGGCAGGAGGTGTCGAGCCCGCCGGTCGCCGCGATGGGCGGCACCTGGACCGTCGAGGCGGACGGCGAGGAGCGCTGCCGGGTGCGGCTGCTGCACGACTACCGTGCCGTCGACGACGACCCGGCCGCACTGGAGTGGATCGCCGCCGCCGTCGACCGCAACAGCCGGGCCGAACTGGACGCGCTGAAGACCCACGCGGAGGCGGCGGCCGACGGTTCGAGCCCGCTGTTCTCGTTCGAGGACAGCCGCCGGATCGCCGGACGCGCGCAGGACGTCTTCGACTTCGTCAACGAGGCGGACCTGTGGCCGCGGCGGCTGCCGCACGTCGCCCGGGTGCGGCTGGAGGACGAGGACGGACTGCAGCTGCTGGAGATGGACACCCACGCGCCCGACGGGTCGGTGCACACCACCACGTCGGTCCGCGTGTGCCTCGCCCCGCACCGCATCCACTACAAGCAGATCCAGGTCCCGGCCCTGATGTCGCTGCACACGGGGGAGTGGCGGTTCGAGGAGGACGCCGACGGCGTCCTGGCCACGTCCCGGCACACCGTCGCCGTCGACGAGTCCGCCGTCAAGGCGGTCCTCGGCGAGGACGCCACCCTTGAGGACGCCCGGGCCATGGTCCGCAAGGCCCTCGGCGCCAACAGCCTGAGCACCCTCGACCGGGCCAAGGCCCACGTCGAGGGCGGCGGTTCATGA	MSGPKVHEAEHHITVAASAKAVHQLLVEVENWPLLFPPSVHVERLEQDGEHERIRIWATANGAAKTWTSRRRIDAAEGRIEFRQEVSSPPVAAMGGTWTVEADGEERCRVRLLHDYRAVDDDPAALEWIAAAVDRNSRAELDALKTHAEAAADGSSPLFSFEDSRRIAGRAQDVFDFVNEADLWPRRLPHVARVRLEDEDGLQLLEMDTHAPDGSVHTTTSVRVCLAPHRIHYKQIQVPALMSLHTGEWRFEEDADGVLATSRHTVAVDESAVKAVLGEDATLEDARAMVRKALGANSLSTLDRAKAHVEGGGS	MKPVAMTLLALALSGCSLAPTHERPAAPVPAQYDTPAQPGQAAAPQDWRAYFNDPALQAWIAAALANNRDLRVAALRIEEARALYGVQQSERLPAIDASGEFSRGRATEPGQPRTPVSNRYRAAVGITAFELDFFGRVRSLSDAALARYLASEEAHRAATLALVAETATAYFNQRSLAEQLRLTDDTLALRETTLKLTQRRYDAGLETAIGLRTAQMLVESSRATRAELTREASLARHALGLLAGDFALPLGVDPTPLESQSLTPLAAGLPSELLTRRPDLRQAEQALRAANADIGAARAAFFPSVQLTTDIGTTADRFSDLFSGGTGGWSFAPRLTLPIFNAGRNRANLSLAETRKHIAVAQYEGSIQAAFRDVADALSARDALRDQIEAQRKVRDADRERQRLAERRYARGVANYLEMLEAQRSLFESEQEFIRLQQRRLVNAVDLYKALGGWDDGSSPAS	67.82	gnl|BL_ORD_ID|2475|hsp_num:0	2796		
BGC0000211.1|Chrysomycin_9 # 6048 # 7523 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.770	BGC0000211.1|Chrysomycin_9 	6048	7523	+	Loose	900	222.631	iri	35.81	3002884	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGACGCCGCCGGACGCCACCGAACAGACGCGGGTGCTCGTGGTCGGTGCCGGCCCCGTGGGGCTGCTCCTCGCGGGCGACCTGCGGCGGTACGGAGCGGAGGTCGTCCTCGTCGACCGGCTCGCGCGGCCGATGACCGAGTCCCGGGCGTCGCAGCTCAACGCCCGCACCATGGAACTGCTCGACCAGCGCGGCCTGGTGGACGGGCTCGGCGGACCCCAGCCGGAGAGCGCCGGCCACTTCGGGGGCCTGCCCTTCGACGCGGCCGGCACGGCGAGCCGCTACGCGGGCAACTGGAAGGTCCCCCAGTTCCGCACCGAGGCGGCCCTGACCCGGTGGGCGCTCGCGGCCGGCGTCGACCTGCGCCGGGAGCACGAACTGTGCGAACTCCGCGTCACCGACGAGGCGGTGACCGCCGTCCTGCGGACCCCGACGGGCCCGCGCACCGTGCGCGCCGCGTACGTCGTCGGCTGCGACGGCGCCGGGAGCACCGTACGCGCCCTCGCCGGCTTCGAGCTCGCGGGCAACGACGCCGTACGGGAGCTGCTGCGCGCCGACATCCAGGGCGTACGGGTGCCCGACCACCGGTTCGAACGCCGTGCACGAGGCTTCGCCGCCTCCGCGCGGCGCCCCGACGGCGTCACCCGCGTGATGGTGCACGAGTCCGGCCGGCCCCCGGCCCGCCGCACCGGCCCCCCGCCCTTCGCCGAGGTCGTCCGCGCCTGGCGGACGGTCACCGGCGAGGACATCAGCGGCGCCGCACCGGTCTGGCTCGACTCCTTCGACGACGCCTGCACACAGGCCACCCGGTACCGGCGCGGCCGCGTGCTGCTCGCGGGCGACGCGGCCCACGTCCACATGCCCGTCGGGGGACAGGCGCTCAACCTCGGCCTGCAGGACGCGGCCAACCTCGGCTGGAAACTGGCCGCGAGCCTGCACGGCTGGGCGCCACCGGGCCTGCTCGACAGCTACCACGAGGAGCGGCACGCCGTCGGCGGACGGGTCCTGGACAACGTACGGGCGCAGGGACTGCTGCTGTTCGGCGGAGGTGAGGCCGACCCGGTGCGGGCGGTGTTCGGCGAACTGCTGGCCGAGACCGGCGCCGGGGACCTGCTGGCCCGCATGGTGAGCGGCCTCGACGTGCGCTACGACACGGGCCCCGGCCGGGCGCCGCTGCTGGGCGCGCGCATGCCCGACCTCGACCTGACCGTCGACGGCGGTCCCACGAGGGTGGCCCGGCTGCTGCACGACGGGCACGGGGTCCTGCTCGACCTCACCGGGGACGGCGCCGGCGCCGCGCGCTTCCGCGCGGCGCTGCCCGCGGGGGCCCGCCAGGTGCGCGTCGTCACCGCGCGCCCCGTGCGGGAGCACCCCGACGGAGCGGTGTTCCTGCTGCGGCCCGACGGACACGTCGTGTGGACCGACCGGGTGCGGGCCCCCCTGGCAGGGGCGGCGCGGCGGTGGTTCGGCGTCTGA	MTPPDATEQTRVLVVGAGPVGLLLAGDLRRYGAEVVLVDRLARPMTESRASQLNARTMELLDQRGLVDGLGGPQPESAGHFGGLPFDAAGTASRYAGNWKVPQFRTEAALTRWALAAGVDLRREHELCELRVTDEAVTAVLRTPTGPRTVRAAYVVGCDGAGSTVRALAGFELAGNDAVRELLRADIQGVRVPDHRFERRARGFAASARRPDGVTRVMVHESGRPPARRTGPPPFAEVVRAWRTVTGEDISGAAPVWLDSFDDACTQATRYRRGRVLLAGDAAHVHMPVGGQALNLGLQDAANLGWKLAASLHGWAPPGLLDSYHEERHAVGGRVLDNVRAQGLLLFGGGEADPVRAVFGELLAETGAGDLLARMVSGLDVRYDTGPGRAPLLGARMPDLDLTVDGGPTRVARLLHDGHGVLLDLTGDGAGAARFRAALPAGARQVRVVTARPVREHPDGAVFLLRPDGHVVWTDRVRAPLAGAARRWFGV	MSDVIIVGAGPTGLMLAGELRLQGVDVVVVDKDEEPTQFVRALGIHVRSIEIMEQRGLLDKFLAHGRKYPLGGFFAGISKPAPAHLDTAHGYVLGIPQPEIDRILAEHATEVGADIQRGKRVVAIRQDTDNVAAELSDGTTLHARYLVGCDGGRSTVRKLRSTSVFPASRTSADTLIGEMDVTMPADELAAVVAEIRETHKRFGVGPAGNGAFRVVVPAAEVADGRATPTTLDDIKQQLLAIAGTDFGVHSPRWLSRFGDATRLADDYRRDRVFLAGDAAHIHPPMGGQGLNLGVQDAFNLGWKLAAEINGWAPVGLLDTYESERRPVAADVLDNTRAQAELISTAAGPQAVRRLISELMEFEDVKRYLTEKITAISIRYDFGEGDDLLGRRLRNIALTRGNLYDLMRSGRGLLLDQGGQLSVDGWSDRADHIVDTSTELEAPAVLLRPDGHVAWIGDAQAELDTQLSTWFGRSARDRA	102.51	gnl|BL_ORD_ID|750|hsp_num:0	796		
BGC0000211.1|Chrysomycin_10 # 7586 # 8854 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.708	BGC0000211.1|Chrysomycin_10 	7586	8854	+	Loose	750	198.364	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	34.98	3003463	protein variant model	F413L	n/a	isoniazid	antibiotic target alteration	antibiotic resistant kasA	ATGAGGCGGCGAGTTGTCATCACCGGCATAGGAGTGCTGGCACCGGGAGGTGTCGGCACCAAGAATTTCTGGTCGCTGATCAGCGAGGGACGCACGGCGACGCGCACCCTGACGCGTTTCGACCCCACCCCGTACCGCTCACGGGTCGCGGCCGAGGTCGACTTCCGCCCGCAGGAGCACGGCCTGCGGGCCCAGGAGATACGCCGGATGGACCGCGCGGCGCAGTTCGCGGTGGTCGCCACCCGCGAGGCGGCGGCCGACAGCGGACTCGAACTGTCCGAACTGGACCCCTGCCGCACCGGCGTGACCATCGGCAGCGCCGTCGGGGCCACCACCAGCCTGGAGGACGAGTACCGGGTGGTGAGCGACGACGGCGCGGCCCGTCTCGTCGACCACGCGTACGCCACCCCGCATCTGTACGACTACCTCGTGCCGAGCTCGTTCGCCGCCGAGGTGGCGTGGTCGCTCGGTGCCGAGGGGCCGAGCACCGTGGTGTCCACCGGCTGCACCTCGGGCATCGACGCGGTGGCGCACGCCGTCGAGCTGATCCGCGAGGGCAGCGCCGACGTGATGATCACGGGCGCGACCGAGGCCCCGCTGTCCCCGATCACCGTCGCCTGCTTCGACGCGATCAAGGCGACGACCGTGCACAACGACGACCCCGAACACGCCTCCAGGCCCTACGACAGCACCCGCAACGGCTTCGTCCTCGGCGAGGGCGCGGCGGGATTCGTACTGGAGGAGTACGAGAGCGCGAGGCGGCGTGGCGCCACCGTCTACGCGGAGATCGTCGGCTACGCCACCCGCAGCAACGCCTACCACATGACCGGACTGCGCCCGGACGGCGCGGAGATGGCCGATGCCATCACCGCGGCGCTCGACGAGGCCCGCCTCGACCCGGGCGACCTCGACTACGTCAACGCCCACGGGTCCGGCACCAAGCAGAACGACCGCCACGAGACCGCCGCGTTCAAGCGCAGCCTCGGCGAGCACGCCTACCGCCTGCCGGTGAGCTCCATCAAGTCGATGGTGGGCCACTCGCTCGGGGCGATCGGGTCGATCGAGATCGCCGCGTCCGTGCTGGCCGTCAAGGAGAACGTCGTGCCGCCCACCGCCAACCTGCACCGGCAGGATCCCGAACTCGACCTGGACTACGTGCCGTTGACCGCGCGCGACTGGAAGACCGACCGGGTGCTCACCGTGGGCAGCGGGTTCGGCGGTTTCCAGAGCGCGATGGTGCTGGCACGGCCCGGAAGGAGCACCGCATGA	MRRRVVITGIGVLAPGGVGTKNFWSLISEGRTATRTLTRFDPTPYRSRVAAEVDFRPQEHGLRAQEIRRMDRAAQFAVVATREAAADSGLELSELDPCRTGVTIGSAVGATTSLEDEYRVVSDDGAARLVDHAYATPHLYDYLVPSSFAAEVAWSLGAEGPSTVVSTGCTSGIDAVAHAVELIREGSADVMITGATEAPLSPITVACFDAIKATTVHNDDPEHASRPYDSTRNGFVLGEGAAGFVLEEYESARRRGATVYAEIVGYATRSNAYHMTGLRPDGAEMADAITAALDEARLDPGDLDYVNAHGSGTKQNDRHETAAFKRSLGEHAYRLPVSSIKSMVGHSLGAIGSIEIAASVLAVKENVVPPTANLHRQDPELDLDYVPLTARDWKTDRVLTVGSGFGGFQSAMVLARPGRSTA	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	101.44	gnl|BL_ORD_ID|2018|hsp_num:0	1943		
BGC0000211.1|Chrysomycin_11 # 8851 # 10059 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.735	BGC0000211.1|Chrysomycin_11 	8851	10059	+	Loose	750	29.6462	mefC	31.08	3003745	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACGGTCGTCGCGGTCACCGGCATCGGTGCCATCGCGCCCAACGGACAGGGCACCGAGGCGTACTGGAAGTCCACCGTCGAAGGGATCGGCGGTATCGCCGAGATCAGCCGGTTCGACGCCTCCGCCTACCCGTCGAAGCTGGCCGGCGAGGTGGTCTTCGACGCCCCCGCGCACCTGCCCAGCAGGCTGATCCCGGCGACCGACCACATGACGCGGCTCGCCCTCGCCGCCGCGGACTGGGCGCTCGAGGACGCGGCGGTACGGCCCGCGGACCTGCCCGACTTCAGCACCGGCGTCATCACCGCCGGTTCCGCCGGAGGCTTCGAACTCGGCCAGCGCGAGCTGGAGAACCTGTGGAGCAAGGGCTCCAAGTACGTCAGCGTGTACCAGTCCTACGCCTGGTTCTACGCCGTCAACTCCGGTCAGATCTCCATCCGGCACGGGATGCGCGGACCCAGCGGCGTGGTCGTCGGCGACCACGCGGGCGGCCTCGACGCGATCGCCCAGTCCCGGCGCCAGATCCGCAAGGGCACCAGCCTGATCGTCTCCGGCGCCGTGGACGGCTCCCTGTGCCCCTGGGGCTGGGTCGCGCAGATGACGGACCCCCGGATGAGTTCCGCCGCCGACCCACGGGAGGCGTACCTGCCCTTCGACCCGAGGGCCGGCGGGTACGTGCCGGGCGAGGGCGGCGCGCTGCTCGTGATGGAGGACCTGGAGCACGCCCGCGGGCGCGGAGCGCGGATCTACGGCGAGGTCGCCGGATACGGCGCGACCACCGACCCCAGGCCGGGCAGTTCACGCGAACCCGGTCTGCGTCGCGCGCTCACGCTCGCGCTCGACGACGCGGGGGCCGCCCCGGAGGACGTCGACGTCGTCTTCGCGGACGCGGCCGCCGTGCCCGAACTCGACCGCGTCGAGGTCGAGGCGATCAACCGTGTCTTCGGCGCCGGCCGGGTGCCGGTCACCGCGCCGAAGACGATGACAGGCAGGCCGGCGGCCGGGACGGCGGCGCTGGACGTCGCGGGGGCGCTGCTGGCGATCCGGGACGGCGTGATCCCGCCGACCGTGAACGTCACGCGCGCCCCCGCCTACGACATCGACCTGGTCACCGGGAGCGCGCGCCGGGCTCCCGTGCGGACCGCGGTCGTACTGGCCAGGGGCCACGGCGGCTTCAACTCCGCGGTCGTGGTGCGCGAGGCGCGATGA	MTVVAVTGIGAIAPNGQGTEAYWKSTVEGIGGIAEISRFDASAYPSKLAGEVVFDAPAHLPSRLIPATDHMTRLALAAADWALEDAAVRPADLPDFSTGVITAGSAGGFELGQRELENLWSKGSKYVSVYQSYAWFYAVNSGQISIRHGMRGPSGVVVGDHAGGLDAIAQSRRQIRKGTSLIVSGAVDGSLCPWGWVAQMTDPRMSSAADPREAYLPFDPRAGGYVPGEGGALLVMEDLEHARGRGARIYGEVAGYGATTDPRPGSSREPGLRRALTLALDDAGAAPEDVDVVFADAAAVPELDRVEVEAINRVFGAGRVPVTAPKTMTGRPAAGTAALDVAGALLAIRDGVIPPTVNVTRAPAYDIDLVTGSARRAPVRTAVVLARGHGGFNSAVVVREAR	MENRKWFKTYMFIWAGQFASMLTSYAVQFAIVIWLSLEYKSAEVLAYAGIAAMLPQALIGLIAGVYVDRLNRKYVMIFSDAFIALCALLLLVILQNENVNLIWIYILLGLRSVGNAFHAPALQAIAPLIVPQNELIKVAGINQVLHSVCRIGGPAIGTLAIAYLPISKVLYLDLIGALLAILSLVMVKIPNVVAKSKSSAHSIATEFSEGFQTVSKNKGLRYLFLYAMAITFVIMPAAIMFPLLTTGHFAGGKWEIGIVEVVWGGGMLIGGVILSIFKLKGSKVVAVNVMYVLLGLTFILSGVLPASWFVGFVMVTAIGGISLSVFNGCFTAIVQTEVSPEKLGRVFSLYYSLAVLPSVIGLLFTGLIAEVIGVNITFIISGCLAILVGILSFSTRNLMQLGKIKNI	98.77	gnl|BL_ORD_ID|2101|hsp_num:0	2262		
BGC0000211.1|Chrysomycin_13 # 10415 # 11599 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.706	BGC0000211.1|Chrysomycin_13 	10415	11599	+	Loose	1000	26.1794	MCR-7.1	25.86	3004517	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGACGACCAGCACCGTCCCCCGCAGCGACATCGACCCCTACAGCGACGCGTCGATCCTCTCCCCGTACGAGGACTACCGGCGGCTGCGCGACCTCGGACCCGTGGTGTGGCTGGAGTCCCACCAGGTCTTCGCGGTCGCCCGGTACCGGGAGGTCTACGACGCGCTGCACGACCACACGACGTTCTCGTCGGGCTCCGGCGTGGGACTGACCGAGACGCTCAACAAGGCGCAGAAGGGCAGCAGCTTCACCAGCGACCCGCCGTACCACGGCTACGTACGCGGGCTGGTGGCCCGGCACCTGAAGCCGAAGGCGCTGGAGCGGTTCCACGACTACATCGAGGGCTGGGCGAACCGGCTCGTCGACGAACTCATCGAGAAGGGCACGTTCGACGCGGTCACCGACTTCGCCCAGGCCTTCCCGCTGGCGGTCGTCCCCGACCTGCTCGGCTGGCCCGTCGAGGAGGGCAAGGAGCGGCTGCTGGAGTGGGCGACCGCCGGCTTCAACGCCTTCGGCCCCCTCAACGAGCGCACCATGTCCGGCTTCCCGCTGCTCAAGGAGATGTCCGAGTTCCTCCAGCGGATGTCGGTCCCCGGAAACCTGCGGCCGGGCAGCTGGGGCGCCGAACTCGTCAGCGACGCCAAGGAGGGCAGGATCGAGGAGTACCTGCTGCCGGGTCTGCTCGGGGACTTCCTCGCGCCCTCGATGGACACCTCCGTCAGCGCGCTGTCCAGCATGCTCTGGCTGTTCGGCGCGCATCCGGACCAGTGGCGGCTGCTGCGCGAGGACGAGGAGCGCATCCCGCACGCCTTCAACGAGATCCTGCGCATCGAGTCCCCGCTGCGCGGCTTCACCCGGCTCACCACGCGCGAGCGCGACCTGGGCGGCGCCCCGCTGGCGGCCGGCTCGCGCGTGCTGCTGCTGTACGGCTCGGCCAACCGCGACGAGCGCCAGTGGGACGACCCCGAGCGGTTCGACATCGGCCGGCCCGGGGTCGCGCAGCACATCGGCTTCGGCCACGGCATCCACGGCTGCGTCGGCCAGGCGCTCTCCCGGCTGGAGGGGCACAGCCTCCTGAAGGCGCTGTCCACGCGGGTGCGCTCGATCGAGATCGGTGAACCCGCCTGGCGGCTGCACAACACGATCCGGGGCATCGCGTCCCTGCCCGTGACGCTGCGGACCTGA	MTTSTVPRSDIDPYSDASILSPYEDYRRLRDLGPVVWLESHQVFAVARYREVYDALHDHTTFSSGSGVGLTETLNKAQKGSSFTSDPPYHGYVRGLVARHLKPKALERFHDYIEGWANRLVDELIEKGTFDAVTDFAQAFPLAVVPDLLGWPVEEGKERLLEWATAGFNAFGPLNERTMSGFPLLKEMSEFLQRMSVPGNLRPGSWGAELVSDAKEGRIEEYLLPGLLGDFLAPSMDTSVSALSSMLWLFGAHPDQWRLLREDEERIPHAFNEILRIESPLRGFTRLTTRERDLGGAPLAAGSRVLLLYGSANRDERQWDDPERFDIGRPGVAQHIGFGHGIHGCVGQALSRLEGHSLLKALSTRVRSIEIGEPAWRLHNTIRGIASLPVTLRT	MRITLGVMKVNLLLVLFFALVLNWPFFLRFYSVISGLEHVRAGFVISVPLVLLAALNAVFIPFTFRWLLKPFFSLLILTGSIVSYAMLKYGVIFDASMIQNIVETNNSEATSYLNVPVVLWFLLTGVLPMVVLWSLKVRYPANWYKGLAIRAGALAFSLLFVGGVAALYYQDYVSIGRNHRILGKQIVPANYVNGIYKYARDVVFATPIPYQPLGTDAKVVAKGDKPTLMFLVVGETARGKNFSMNGYEKETNPFTSQAGGVISFKDVRSCGTATAVSVPCMFSNMGRKEFDDNRARNSEGLLDVLQRSGVSIFWKENDGGCKGVCDRVPNIEIKPKDHPQFCDKNTCYDEVVLQNLDDEVAQMKGDKLVGFHLIGSHRPPYHQRYPDKPPPFVPDCPRSDIENCSDEELVNTYDNTIRYTDFVIAEMITKLKKYEDKYNTALIYLSDHGESLGAMGLYLHGTPYKFAPDDQTRVPMQVWMSPGFAKEKGMDLNCLQQKAADNRYSHDNLFSSVLGIWDVSTAVYDKQLDIFSQCRTVQ	73.10	gnl|BL_ORD_ID|2741|hsp_num:0	3145		
BGC0000211.1|Chrysomycin_14 # 11833 # 12819 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.738	BGC0000211.1|Chrysomycin_14 	11833	12819	+	Loose	210	27.7202	Escherichia coli marR mutant conferring antibiotic resistance	33.33	3003378	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGAGGTGGTGCCGGCGATGAGCACGACAGCCTTCGTGTTCCCGGGCCAGGGTTCCCAACGGGTCGGCATGGGACGCGCTCTGACCGAGCGGCGGCCGGACCTGCTCGACTCCCACTACCGGGTCGCGGACGAGGTGCTGGGGATCCCCCTGACACAGCTGTGCTGGAGGGGCCCGGCCGAGGAACTGCGGGCCATGCCCGTCACCCAGCCCGCCGTCTTCCTGACCAGCGTCGTCACCCATGAGGTGCTCGGCGGGCAGGGGGTCGTCCCCGACGTCGTGGCCGGACACAGCCTCGGCGAGTTCGCGGCGATGGTCACCGCGGGGGTGCTCGACTGGGTCGACGTCGTGCACCTGGTCCGGCTGCGGGGCCGGCTGATGGACGCGGTCAACCGCGAGATCCCGGGCAGCATGGGCGCGGTCATCGATGTCGAGTTGGGTGAACTGGAGGGCCTGTGCGCCCGGGCCGCCGCCGACACGGGCGAGATCGTCGAGATCGCCAACCACAACGACCACCGGCAGATCGTGGTCGCCGGGCAGACCGGCGGTGTGGCGCGCCTCCTCGAACTCGCCGAACGGGGCGGGGCCCAGCGGGTACTGACGCTCGACGTGGGCGGGTCGGCGCACTGCAGCCTCCTGTCCGGCATCGAGCCGGAGTTCCGGCGGGCGGTCGAGGCGCTCGACCTGCGCGATCCGGTCGTCCCCGTGATCTCGGCGGTGACGGCGGCCCCCGTCCGTACGGCCGCCGAGGCCGCCGACTGCCTGTCGCGGCAGTTCACCCACCGGGTGCGGTGGACGGAGACGGTGGAGGCGCTGACCGCGGCGGGCGTCGGCCGGTTCGTGGAGGTGGGGCCCGGCAGGACGCTGAGCAAGCTCTGCGGCCGGCTGGCCCCGGACGCGGAGACGTACCGGACCAACGACACCGAGCACGTCGACCGGGTGGCCGAGGCCCTCGGCACCGCGCGGCCGGCCCGGGCGCGGCTGTGA	MEVVPAMSTTAFVFPGQGSQRVGMGRALTERRPDLLDSHYRVADEVLGIPLTQLCWRGPAEELRAMPVTQPAVFLTSVVTHEVLGGQGVVPDVVAGHSLGEFAAMVTAGVLDWVDVVHLVRLRGRLMDAVNREIPGSMGAVIDVELGELEGLCARAAADTGEIVEIANHNDHRQIVVAGQTGGVARLLELAERGGAQRVLTLDVGGSAHCSLLSGIEPEFRRAVEALDLRDPVVPVISAVTAAPVRTAAEAADCLSRQFTHRVRWTETVEALTAAGVGRFVEVGPGRTLSKLCGRLAPDAETYRTNDTEHVDRVAEALGTARPARARL	MKSTSDLFNEIIPLGRLIHMVNQKKDRLLNEYLSPLDITAAQFKVLCSIRCAACITPVELKKVLSVDLGALTRMLDRLVCKGWVERLPNPNDKRGVLVKLTTGGAAICEQCHQLVGQDLHQELTKNLTADEVATLEYLLKKVLP	227.78	gnl|BL_ORD_ID|2039|hsp_num:0	431		
BGC0000211.1|Chrysomycin_16 # 13911 # 14708 # -1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.685	BGC0000211.1|Chrysomycin_16 	13911	14708	-	Loose	300	25.409	AAC(3)-VIIIa	37.93	3002542	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGGTCTGCATAACGCACCCTCACATCCACCCTGAATACCGTGCGACCGATTGCCGGAACGACACGTCGGGCAGTCTGTGCACCGACTGCGAGGAACACCTCTCGGGAATGCTGCAAAGGATTCCGACACTTTACCTGAGCTGTGAACTAAGCCTTGGCGGAGCGAATGCGGCCGAGGAAAGGGTCACCAGCTCCAACAGCCACCAGGGCATGCCGTTCAACGCGGCGGCCGCCGAGGTCCGCTCCTCGATCATGTCGGTCCTGGCCTCCTGGGCCGGCCTCGTCGCCGCGGAGCGGGCGGTCGACGCCCCGCAGCGCCACGTCGTGGGAATGGCCCGCTTCCTCCACGAGAACATCCCCTGGCTCTCGGCCCATCCGGCGGCCCACGACCTGCTCGACGAACTCACCACCCTGACGCGGCTCGCCCGGCGCGCGAGCGACTCCCGCAGCATCCGCGTCATCCCGGTCGGCCCGTGCGTACGGGAAGGCTGCGCCGGCAAGCTGCGCGCCGTGGTCAAGGTCGTCCCCGGCACCCGGCCGAAGCCGTCCGAGATCCGGTGCAGCGCGGACCGTACGCACTGGTGGGCCTCCAGCGAGTGGTCGGCCCTCGCGTCGCGCATGGGGACGCTCCGCGATCACCGGCGCACCTGGTACAGCGTCGCGGACATCGAAGTGCTCTGGAAGATCCCCAGCGGAAGCATCTACCGCCTCGCCAACCAGTACCGGTGGCGCCGCCGCAAGATCTCGGGCCGGGTCTTCTACCACGCCGAGGACCTCCACGACTCGCTCCCCGGCTGA	MVCITHPHIHPEYRATDCRNDTSGSLCTDCEEHLSGMLQRIPTLYLSCELSLGGANAAEERVTSSNSHQGMPFNAAAAEVRSSIMSVLASWAGLVAAERAVDAPQRHVVGMARFLHENIPWLSAHPAAHDLLDELTTLTRLARRASDSRSIRVIPVGPCVREGCAGKLRAVVKVVPGTRPKPSEIRCSADRTHWWASSEWSALASRMGTLRDHRRTWYSVADIEVLWKIPSGSIYRLANQYRWRRRKISGRVFYHAEDLHDSLPG	MDEKELIERAGGPVTRGRLVRDLEALGVGAGDTVMVHTRMSAIGYVVGGPQTVIDAVRDAVGADGTLMAYCGWNDAPPYDLAEWPPAWREAARAEWPAYDPLLSEADRGNGRVPEALRHQPGAVRSRHPDASFVAVGPAAHPLMDDHPWDDPHGPDSPLARLAGAGGRVLLLGAPLDTLTLLHHAEARAEAPGKRFVAYEQPVTVGGRRVWRRFRDVDTSRGVPYGRVVPEGVVPFTVIAQDMLAAGIGRTGRVAAAPVHLFEAADVVRFGVEWIESRMGGAAGGA	92.66	gnl|BL_ORD_ID|471|hsp_num:0	501		
BGC0000211.1|Chrysomycin_17 # 14769 # 14993 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.591	BGC0000211.1|Chrysomycin_17 	14769	14993	+	Loose	300	21.1718	dfrA27	26.47	3004550	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGATATGGGGAAGCAATTCCATGGTGGAGTGTCTCCGTCATGAATGTAATAATGGAGAGCAGATGGTTGATCATGGGAAAATCACGAGGTCGCCCGTGCGGAATTCAAGCAGGCCGCACATCCGCGGGCATGACGAAGCCCCCACCGGGACGGCTTGGTCGGAGCCGCCCCCGCGGGGGCTTTGTCGTTGCGTCTTGAATGAGTGCCGTGACGCGTCCCCGTAG	MIWGSNSMVECLRHECNNGEQMVDHGKITRSPVRNSSRPHIRGHDEAPTGTAWSEPPPRGLCRCVLNECRDASP	MKISLMAAKARNGVIGCGSDIPWNAKGEQLLFKAITYNQWLLVGRKTFEAMGALPNRKYAVVSRSGSVATNDDVVVFPSIEAAMRELKTLTNHVVVSGGGEIYKSLIAHADTLHISTIDSEPEGNVFFPEIPKEFNVVFEQEFHSNINYRYQIWQRG	47.13	gnl|BL_ORD_ID|2761|hsp_num:0	3258		
BGC0000211.1|Chrysomycin_18 # 15081 # 15758 # -1 # ID=1_18;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.643	BGC0000211.1|Chrysomycin_18 	15081	15758	-	Loose	390	52.7582	evgA	20.6	3000832	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGAGCGACCTGACCGGGCGCGGATGGCGGACGCAGGACGCCGAGTGCTCGCGATCACCTCTTGGGGGAAAAGTGATTAACGTCTTGCTCGCCGAAGAGAGGGAAATGACACGAGGGGCATTTCTCGCCCTACTCGCGCAGGAGAGCGACATCAAGACCGTCGCCGACCTGGGTCGGAGCAAGGACATTCTGCCCGCGATCAGACTGCACCGGCCGGACGTGGCAGTCATCGACATGGATATGCTGACCCCGGACGGCCTGTCATCGATTCAGAGCCTTTTCGACGAGCTGCCGGAAACACGTACTCTCATTCTCACCAATCATGGGCGCCCCGGTGTGGTGCGTCAAGCGCTGAACATCGGCGTCGCGGGTTTTCTGCACAAGGACTCACCGCCGGAGAAACTCGTCAGCGCTATAAGGGATCTCGCGGCGGGACGACGTGTCATCGACGCGGATCTCGCGATGTCCGCCTGGCAGACGCCGCTCCCCCCGCTCACCGACCGCGAGCTCGAGGTGCTCCGCCTGACCGCCACCGGCGAGGCTGTTCCGGCCATCGCCACACGACTCCACCTGTCCCCCGGCACCGTCCGCAACTATCTGACCACCGTGGAGAGCAAACTCAACGCGCGCACGCGAGTGGACGCCGTGCGCATCGCCACGGACGCCGGCTGGCTCTGA	MSDLTGRGWRTQDAECSRSPLGGKVINVLLAEEREMTRGAFLALLAQESDIKTVADLGRSKDILPAIRLHRPDVAVIDMDMLTPDGLSSIQSLFDELPETRTLILTNHGRPGVVRQALNIGVAGFLHKDSPPEKLVSAIRDLAAGRRVIDADLAMSAWQTPLPPLTDRELEVLRLTATGEAVPAIATRLHLSPGTVRNYLTTVESKLNARTRVDAVRIATDAGWL	MNAIIIDDHPLAIAAIRNLLIKNDIEILAELTEGGSAVQRVETLKPDIVIIDVDIPGVNGIQVLETLRKRQYSGIIIIVSAKNDHFYGKHCADAGANGFVSKKEGMNNIIAAIEAAKNGYCYFPFSLNRFVGSLTSDQQKLDSLSKQEISVMRYILDGKDNNDIAEKMFISNKTVSTYKSRLMEKLECKSLMDLYTFAQRNKIG	110.29	gnl|BL_ORD_ID|958|hsp_num:0	1015		
BGC0000211.1|Chrysomycin_19 # 15930 # 16916 # -1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.703	BGC0000211.1|Chrysomycin_19 	15930	16916	-	Loose	1200	50.447	arnA	26.04	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGACGACCACTCATCTCCTGGTCACCGGCGGGGCGGGGTTCATCGGCTCGCACTACGTGCGCACTCTGCTCTCCCCCGAGGGCCCCGGCGACATCTCCGTCACCGTGCTCGACGCGCTGACCTACGCGGGGAACCCGGCCAACCTCGACCCGGTGCGCGCGCATCCCGGCTTCACCTTCGTCCGGGGCGACATCTGCGACGCGCCGCTGGTGAGGTCCCTCGCCCGTCGCGCCGACCAGATCGTGCACTTCGCCGCCGAGTCGCACGTGGACCGCTCGATCACGGACCCGGCCGCGTTCACCCGGACCAACGTGATGGGAACGCAGATCCTGCTCGACGCGGCGCTGCGCGCCGGTACGCGCACGTTCGTCCACATCTCGACGGACGAGGTCTACGGGTCCATCGACGAGGGCTCCTGGCCGGAGGACCACCCCCTCCGCCCCAGCTCGCCGTACGCGGCGTCCAAGGCGTCGAGCGATCTCCTCGCCCTGAGCCACCACCACACCCACGGCCTGGACGTGCGGGTGACCCGGTGCTCCAACAACTACGGGCACCACCACTTCCCCGAGAAGGCCATCCCCCTGTTCGTGACCCGTCTCCTCGACGGAAGGAAGGTGCCCCTGTACGGCGACGGGCGCAACGTCCGGGACTGGCTGCACATCGACGACCACGTGCGGGCCGTCGAGCTGGTGCGCACGAGCGGAAGACCCGGCGAGGTCTACAACATCGGCGGCGGCACCGAGCTGACCAACCGGCAGCTCACCGAGCGGCTGCTCGCGGAGTGCGGAGCCGGCTGGGACATGGTCGAGCACGTGGCCGACCGCCCGGGGCACGACCTGCGCTACTCGGTCGACTGGACCAAGATCCACACCGAGCTGGGCTACCGGCCGCGCAAGGACTTCGCCACGGGGCTCGCCGAGACCGTGGCCTGGTACCGCGAGAACCGCCCGTGGTGGGAACCCCTGAAGGAGCGCGCCATGCTGTGA	MTTTHLLVTGGAGFIGSHYVRTLLSPEGPGDISVTVLDALTYAGNPANLDPVRAHPGFTFVRGDICDAPLVRSLARRADQIVHFAAESHVDRSITDPAAFTRTNVMGTQILLDAALRAGTRTFVHISTDEVYGSIDEGSWPEDHPLRPSSPYAASKASSDLLALSHHHTHGLDVRVTRCSNNYGHHHFPEKAIPLFVTRLLDGRKVPLYGDGRNVRDWLHIDDHVRAVELVRTSGRPGEVYNIGGGTELTNRQLTERLLAECGAGWDMVEHVADRPGHDLRYSVDWTKIHTELGYRPRKDFATGLAETVAWYRENRPWWEPLKERAML	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	49.55	gnl|BL_ORD_ID|1549|hsp_num:0	1643		
BGC0000211.1|Chrysomycin_20 # 16913 # 17980 # -1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.675	BGC0000211.1|Chrysomycin_20 	16913	17980	-	Loose	450	28.4906	ANT(9)-Ia	34.78	3002630	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(9)	ATGAAGGCGCTCGTCCTCTCGGGCGGTGCGGGTACGCGCATGCGCCCGCTCACGCACACCACGGCGAAACAGCTGGTCCCGGTAGCCAACAAGCCTGTTCTGTTCTACGGCCTCGAAGCCATCGCACAAGCCGGCATCACGGACGTGGGAATCATCGTGGGCGAAACGGCGGACGAGATCGAGGAGGCGGTGGGCGACGGCTCCAAATTCGGACTCGACGTCACCTACATCCCCCAGGAGGCGCCGCTCGGACTCGCCCACGCCGTGCTGATATCCCGCTCATTCCTGGGGGACGATGAATTCGTCATGTATTTGGGCGACAACTTCATCGTCGGCGGCATCACCGAACTGGTGGACAATTTCGTGTCGGACCGCCCCGACGCCCAGATCCTGCTGACCCACGTCCCCAATCCCACCGTCTTCGGCGTCGCCGAGCTGGACGACGCGGGCAACGTCGCGCGCGTGGAGGAGAAGTCCCCCTGCCCCAGGAGCGACCTCGCGATCGTCGGGGTGTACCTGTTCGGTCCGGCCGTCCATGAGGCGGTGCGTGCGATCAAGCCCTCCGGGCGCGGGGAGCTGGAGATCACCCACGCCATCCAGTGGCTCATCGACGAGGGGCGCGACGTGCGCTCCACGACGATCTCCGGCTACTGGAAGGACACCGGCAACGTCGTGGACATGCTGGAGGTCAACCGGTCGGTGCTGGAGACGCTCGAACCCCGGATCGAGGGCGAGGTGGACGAGGCGAGCCAGATCATCGGCCGGGTCCGCATCGAGGAGGGCGCGCGCGTGCGCGGCTCCCGCGTCGTCGGCCCCGCCGTCATCGGCCGGGGCACGGTGATCAGCGACTCCTACATCGGCGCGTACACGTCGGTGTCGGAGGACTGCCGCGTGGAGAACAGCGAGATCGAGTTCTCGATCGTGCTGCGGGACTCGTCGATCAAGGGGGTGCGCCGGGTCGAGGCGTCCCTGATCGGACGCAACGTCACGGTGACGCCGGCCCCGGCCGTCCCGCACGCCCACCGGCTCCTGCTGGGCGACCACAGCGAGGTGCAGATCTCGTCATGA	MKALVLSGGAGTRMRPLTHTTAKQLVPVANKPVLFYGLEAIAQAGITDVGIIVGETADEIEEAVGDGSKFGLDVTYIPQEAPLGLAHAVLISRSFLGDDEFVMYLGDNFIVGGITELVDNFVSDRPDAQILLTHVPNPTVFGVAELDDAGNVARVEEKSPCPRSDLAIVGVYLFGPAVHEAVRAIKPSGRGELEITHAIQWLIDEGRDVRSTTISGYWKDTGNVVDMLEVNRSVLETLEPRIEGEVDEASQIIGRVRIEEGARVRGSRVVGPAVIGRGTVISDSYIGAYTSVSEDCRVENSEIEFSIVLRDSSIKGVRRVEASLIGRNVTVTPAPAVPHAHRLLLGDHSEVQISS	MSNLINGKIPNQAIQTLKIVKDLFGSSIVGVYLFGSAVNGGLRINSDVDVLVVVNHSLPQLTRKKLTERLMTISGKIGNTDSVRPLEVTVINRSEVVPWQYPPKREFIYGEWLRGEFENGQIQEPSYDPDLAIVLAQARKNSISLFGPDSSSILVSVPLTDIRRAIKDSLPELIEGIKGDERNVILTLARMWQTVTTGEITSKDVAAEWAIPLLPKEHVTLLDIARKGYRGECDDKWEGLYSKVKALVKYMKNSIETSLN	136.54	gnl|BL_ORD_ID|1302|hsp_num:0	1386		
BGC0000211.1|Chrysomycin_21 # 18285 # 19937 # -1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.699	BGC0000211.1|Chrysomycin_21 	18285	19937	-	Loose	1050	163.31	facT	30.0	3001313	protein homolog model	n/a	n/a	elfamycin antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGCAAAGATACATCAGAGTGGAGGTACCTTGAACGGCACCACGGAACCCCCATCCATGCGCCAATGGCTCGGCCTGGTGGCAGTTTCCTTGGGTGTGGCGCTGATCGTCGTCGACATCACGATCGTCAACGTCATCCTGGCCCCGATCATCGAGGACCTCTCGATCGATTCCGCCGAGGCCCAGTGGATCCAGGAGTCCTACGCGATCGCCTTCGCGGCCCTCCTCCTGCTCGCCGGACGCCTCGCCGACCTGTACGGCGCCCGCAGGATCTTCGTCTACGGTCTCGTCGTCTTCGCCGTCACGAGCCTGGTGGCCGCCCTCTCCCCCGACGGCGGCCTGCTGATCCTGGCCCGCGCACTGCAGGGGGTCGGCGGCGCCATGATCCTCCCGACCTCACTGGCGCTGGTGAACGCCACCTTCACCGGCAAGGCCCGGGGTCAGGCCTTCGCCATCTGGGGCTCGACCATCGGCGCCGCGGCTGCCGTGGGCCCGCTGCTCGGCGGCTGGCTGGCCGACATCTCCTGGCGCTGGGCCTTCGGCATCAACATCCCCCTGGTCGCCCTGATCATGGTCGGGACGCTCGTCCACCTGTCCGAGTCCCCGCGAACCCGGGGCCGCGTCGACGGAGTCGGCGGCGTCCTGTCGGCGGTCGGCCTCGGCCTGCTGGCGTTCGCCCTGATCGAGGGGCGCACCTACGGCTGGCTGATGACCACCGAGTCCCTCGACGTCGGCGGCCTCTCGTGGAGCGGCGGCCTCTCCCCCGTGTGCGTCTCGTTCGTCGTGTCGGCGGTGGTCCTGTGGGCGTTCTGGCGCCGTCAGGCGGCGCTGGGCCGCAGGAACGGAGAGCCGCTGATGGACGTCGGCCTCTTCTCCATCCCGTCCTTCCGCAACGGCAACGTCGTGACGCTGATGGTCGGACTCGGCGAGTTCGGCATCATCGCCGTACTGCCGCTGTGGCTGCAGTTCACCCTGGACTACAGCGCGTTCGACGCCGGACTCGCGCTCGTCGCGCTCGCGGTGGGCAGCTTCGTCGCCAGCGGAGCGAGTTTCGGCATGGCCGCCACGGTCCCGCCGCTCTCCCAGGTGCGGATCGGTCTCGTCCTGGAGGCCGCCGGCCTGGTGATGCTGGGCCTGATCGCCGCGACCGACACCTCCTGGTGGACGATCGCGATCGCCCTGTTCGTCTACGGCGTCGGCGTGGGCTTCGCGACGGCGCAGGTCACCAACATCGTGCTGGTGGACGTTCCCCCGCGGAGCGCCGGACAGGGGTCGGGCATCCAGAGCGCGGCCCGGGAACTGGGCTCCGCGCTGGGTATCGCCGTCCTGACCACGCTGTTCTTCAGCACCCTCGCCACCGATCTGAACGACCGGCTCACCGACTCCGGCCTGAAGGACGCCGAGGCCGACCGGTTCAGTTCGGTCGTCACGGACAGCGCGGGCTCGGTGATCCAGTCGCTCTCCGACGACAAGCGGACCGCCGCGGTCGCGGACGCGGCCAGAGAGGCGATGTCCCACGGCCTGGCGATGGCCTCCTACGTGTGCGCCGGACTGCTGGCCCTGGCCCTGGTGACCACGCTGTTCGTCACCCCTCGCGAGGGCGCCCCCACCGAGGAGGCGAAGGCCGCGCACCCCGAACCGACCACCAACTGA	MAKIHQSGGTLNGTTEPPSMRQWLGLVAVSLGVALIVVDITIVNVILAPIIEDLSIDSAEAQWIQESYAIAFAALLLLAGRLADLYGARRIFVYGLVVFAVTSLVAALSPDGGLLILARALQGVGGAMILPTSLALVNATFTGKARGQAFAIWGSTIGAAAAVGPLLGGWLADISWRWAFGINIPLVALIMVGTLVHLSESPRTRGRVDGVGGVLSAVGLGLLAFALIEGRTYGWLMTTESLDVGGLSWSGGLSPVCVSFVVSAVVLWAFWRRQAALGRRNGEPLMDVGLFSIPSFRNGNVVTLMVGLGEFGIIAVLPLWLQFTLDYSAFDAGLALVALAVGSFVASGASFGMAATVPPLSQVRIGLVLEAAGLVMLGLIAATDTSWWTIAIALFVYGVGVGFATAQVTNIVLVDVPPRSAGQGSGIQSAARELGSALGIAVLTTLFFSTLATDLNDRLTDSGLKDAEADRFSSVVTDSAGSVIQSLSDDKRTAAVADAAREAMSHGLAMASYVCAGLLALALVTTLFVTPREGAPTEEAKAAHPEPTTN	MNKAGQAEKPAAAGPPATPETPEPDPKRWLALTVLLVATFMDLLDANIITVAIPSIQRDLGASTFAIQAMTAGYTLSFAVLLITGGRLGDIFGRKRMFLVGVGGFVLASAMCAAAPSTDLLVVARALQGLTAAVMVPQVLALIHVSFAPQEIGRVVSLYASMVGLAIVSGPLIGGALISWNPLDLGWRSIFVVNLPVGVLALVGAAKWMRESSSPHAKRLDIAGMLLIVLGLLLLMVPLTLGRELDWPVWSIVSLVAAAPVLVLFVVYERHKTAKDGSPLVTLSLFKVRAFGAGIGVQLLFSAIPAGFFLSWTLYLQAGLGWSALHTGLTAIPFSLCVPIVGGLAVRRLSPLYGRYCLLAGAVLMLAGILSYAWAADRFGTDITSWHAIPSMLLIGSGMGMLMPPLTALVLREVQPQEAGAASGIINATGQLGAALGVAVIGSLFFAALAGNAGPQAERVAPTVQSVSPRQASDLRDCATEALGQDDLAKVPDICSTLVQGADDGTRDTINGALGEIRAKTFVSTYSETLYWAAGGLVPVTALVLLLPHHRVRREEPAQ	98.39	gnl|BL_ORD_ID|1383|hsp_num:0	1469		
BGC0000211.1|Chrysomycin_22 # 20015 # 20542 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=10bp;gc_cont=0.693	BGC0000211.1|Chrysomycin_22 	20015	20542	+	Loose	270	29.6462	mgrA	29.09	3000815	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; penam; tetracycline antibiotic; peptide antibiotic; acridine dye	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump	ATGACGATGGAGAGAGCAGACCTCGGCGGGCTGGAGGTACAGCGCGACCGGCTCATGGACGGGCTGCGCGCCTTCGGTGCCAACTACGCGGAGTTCACCCAGCGGTTCGCGACCTGGCTGGGCCTGCACTCCACCGACGCCGCGGCTCTCGTCGAGATCCTCTACGCCGAGGACAAGGGGGCGCCGCTGTCACCCGCCCGGCTGAGCGAGCGTGTCTCCCTGTCGTCGGGCGCGACGACCGCGCTGCTGAACCGTCTCGAGGCGGCCGGACACATCGTGCGCACCCGTGAACACACCGACCGCAGGATCGTGACCCTGCGCAGCAGCCCCCATGTGAAGCCGCGCGCCGAGGAGTTCTTCGGCCCCTACGCCGGACGCATGGTCGCCGAGATGTCGCAGTACACCCCCGAGCAGCTCCAGCAGTTCGAGGACTTCATCGTCCACCTGCGCGAGACCATGGACTCGCTGCTCGCCCACGAGTACAAGGAGAGCCGGCCGGGCGGCTCAGGAGCGTCCGACCGGGGCTGA	MTMERADLGGLEVQRDRLMDGLRAFGANYAEFTQRFATWLGLHSTDAAALVEILYAEDKGAPLSPARLSERVSLSSGATTALLNRLEAAGHIVRTREHTDRRIVTLRSSPHVKPRAEEFFGPYAGRMVAEMSQYTPEQLQQFEDFIVHLRETMDSLLAHEYKESRPGGSGASDRG	MSDQHNLKEQLCFSLYNAQRQVNRYYSNKVFKKYNLTYPQFLVLTILWDESPVNVKKVVTELALDTGTVSPLLKRMEQVDLIKRERSEVDQREVFIHLTDKSETIRPELSNASDKVASASSLSQDEVKELNRLLGKVIHAFDETKEK	119.05	gnl|BL_ORD_ID|138|hsp_num:0	154		
BGC0000211.1|Chrysomycin_23 # 20814 # 21953 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5bp;gc_cont=0.725	BGC0000211.1|Chrysomycin_23 	20814	21953	+	Loose	700	37.3502	oleD	24.33	3000865	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGAAAGTCCTCTTCATCGCCGCGGGAACGAGCCCGGCGGGGGTCTTCGCCCTCGCCCCTCTCGCGACGGCGGTGCGCAACGCAGGGCACGAGATCCTGGTGGCGGCCTTCGACGAGCTGACCCCGGCCGTCGCGTCCGTCGGACTGCCCGTCGTGGCCGTCGCCGACGGCCACACGACCGAGAGCATCAAGGGACTCGACCGGCCGGGCGGACCGATCGGGTTCCCCTGGGCACCCGAGCAGGAACTGCCGTACGTGGGACGTTGGTTCGGCCGCCAGGCGGCCGTCGCCATGGACGGACTCCTGCGGCTCGCCGACGTGTGGCGCCCCGACCTCGTGGTCGGTGGCACGGACGCCCACGCCGCCGCCCTGCTCGGCTCCCGGCTGGGCATCCCGTACGTCCGCCAGGCGTGGGACTGGCTCCACTTCGACGGAGCGGAGCGCTACGCGAACGACGAACTGGCCCCCGAACTGGCGCAGGCCGGACTCGAACGGCTCCCGGCACCCGACCTGTTCATCGACATCTGCCCGCCGAGCCTGATCCCGCCGGGCGCCGAGCGCGGCCGGCCGATGAGATGGGTGCCGGGCAACCGCCAGCGCAAGCTGGAGCCGTGGATGTACGGCAAGGGCGAGCGCGCCCGGGTGTGCGTCACGCTCGGCAGCTTCCGCACCGCCATGCCGGAGATGTTCGCCTACCTGTGCGCACTGGTGGAGCGGCTGACGGCACTCGACGCCGAGATCGTCGTCGCCGCCGACGAGACGGCCTCCCGGAAGATCCGGGAGCGCTTCCCCGGCGTACGCGCCGACTGGGTGCCGATGGAGTTCCTCGTGCGCACCTGCGACACGATCGTGCACGCGGGCGGCCTCACCACTCTCAACGCCATGGCGGCCGGCACCCCGCAGGTGGTGGTGAACCAGTTCCAGGCGTTCGAACCCTCGCTGCGGCTGCTCGAGCGGCAGGGATGCAGCGTGGTCCTGCACCGGGACGACAAGTCCCCGGACAACACCTTCGACGCCTGCGAGCGCATCCTCTCCGACGACGGGTACGCGCACCGGGCAGGTGAGCTGGCCCGCGAACTGGGCGCCCTGCCCCCGCCGGCCACGGTCGTCGGCGACCTGGAGGCGCTGGCCCGCCGCTGA	MKVLFIAAGTSPAGVFALAPLATAVRNAGHEILVAAFDELTPAVASVGLPVVAVADGHTTESIKGLDRPGGPIGFPWAPEQELPYVGRWFGRQAAVAMDGLLRLADVWRPDLVVGGTDAHAAALLGSRLGIPYVRQAWDWLHFDGAERYANDELAPELAQAGLERLPAPDLFIDICPPSLIPPGAERGRPMRWVPGNRQRKLEPWMYGKGERARVCVTLGSFRTAMPEMFAYLCALVERLTALDAEIVVAADETASRKIRERFPGVRADWVPMEFLVRTCDTIVHAGGLTTLNAMAAGTPQVVVNQFQAFEPSLRLLERQGCSVVLHRDDKSPDNTFDACERILSDDGYAHRAGELARELGALPPPATVVGDLEALARR	MTTQTTPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPVFADKVAATGARPVLYHSTLPGPDADPEAWGSTLLDNVEPFLNDAIQALPQLADAYADDIPDLVLHDITSYPARVLARRWGVPAVSLSPNLVAWKGYEEEVAEPMWREPRQTERGRAYYARFEAWLKENGITEHPDTFASHPPRSLVLIPKALQPHADRVDEDVYTFVGACQGDRAEEGGWQRPAGAEKVVLVSLGSAFTKQPAFYRECVRAFGNLPGWHLVLQIGRKVTPAELGELPDNVEVHDWVPQLAILRQADLFVTHAGAGGSQEGLATATPMIAVPQAVDQFGNADMLQGLGVARKLATEEATADLLRETALALVDDPEVARRLRRIQAEMAQEGGTRRAADLIEAELPARHERQEPVGDRPNGG	91.33	gnl|BL_ORD_ID|1284|hsp_num:0	1367		
BGC0000211.1|Chrysomycin_24 # 22072 # 23094 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=11bp;gc_cont=0.737	BGC0000211.1|Chrysomycin_24 	22072	23094	+	Loose	300	30.8018	AAC(3)-Xa	38.6	3002544	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGCAGACCACACCCCCCAAGCCGCCGCCCTCCGCACAGGTGCTGCAGCTCGCGACGTCGAGCTGGACGGCCGCCGCCGTGAGCGCCGCCGCCGAACTCGGCGTCGCCGACGCGCTGGCGGACGGAGCCCGCCCGTCCGACGAGATCGCCCGGAGCGTCGGCGCGCACCCGCCCACCTGCTACCGCCTGCTGTGGGCCTGCGCCGCCATCGGGCTGCTGGAGGAGAGCGAGGGGCGGGTGTTCGCCCTCACCGAGGCCGGTGACGCGCTCCGCGGCGACTCGCCACACTCCATGCGCAACTTCGCCCGGTGGGTCGGCCTCGCCGCCGACCGCAACACCTGGGCCGGCCTCGCCGACAGCGTCCGCACCGGCGATCCCGCGTTCGCGCGGGTGCACGGCCAGGACGTGTGGGAGTACATGAGGGATCGCGCCGACGTCTCGACGGTCTTCGACGACGCGATGACCGAGGCGTCGCGTCAGCTGATCGCCCCGGTGGTCGACGCCTACGACTTCGGCGGCACCGGCACGCTCGTGGACGTCGCGGGCGGGCACGGAGCCCTCCTCGCCGCGATCCTCGCCGCCCACCCGGGCCTCCGCGGCCTGCTGTACGACCGGCCCGAGGTGGTGGAGGGGGCGAAGCAGACGTTCCAGGACCGCGGGGTGGACGACCGGGTGGAGATCGTCGCCGGCGACTTCTTCGACTCCGTGCCGGAGGGCAAGGACGCCTACCTGCTGTCGAACGTCATCCATGACTGGGACGACGAGCCGTCCCTGACGATCCTCGGCAACTGCCGCCGCGCGCTCGCCGAGGGCGGCCGGGTGCTCCTCGTCGAGGCCGTCATGCCGGAGCGGGACGCGTCCTCGCCGACCGTGACCCTGATGGACCTCAACATGCTCGTGCTCTGCGGCGGCAAGCAGCGCACCGAGACCGAGTTCGCCGAACTCCTCGGCCGCGCCGGTCTCCGCCTCACCCGCGTCGTCCGGGCGGGACTGCACAGCGTCGTCGAGGCCGTCCGCGCCTAG	MQTTPPKPPPSAQVLQLATSSWTAAAVSAAAELGVADALADGARPSDEIARSVGAHPPTCYRLLWACAAIGLLEESEGRVFALTEAGDALRGDSPHSMRNFARWVGLAADRNTWAGLADSVRTGDPAFARVHGQDVWEYMRDRADVSTVFDDAMTEASRQLIAPVVDAYDFGGTGTLVDVAGGHGALLAAILAAHPGLRGLLYDRPEVVEGAKQTFQDRGVDDRVEIVAGDFFDSVPEGKDAYLLSNVIHDWDDEPSLTILGNCRRALAEGGRVLLVEAVMPERDASSPTVTLMDLNMLVLCGGKQRTETEFAELLGRAGLRLTRVVRAGLHSVVEAVRA	MDETELLRRSDGPVTRDRIRHDLAALGLVPGDTVMFHTRLSAIGYVSGGPQTVIDALLDVVGPTGTLLVTCGWNDAPPYDFTDWPPAWQEAVRAHHPAFDPRTSEAEHANGRLPEALRRRPGAVRSRHPDVSLAALGASAPALMDAHPWDDPHGPGSPLARLVALGGRVLLLGAPRDTMTLLHHAEALAQAPGKRFVTYEQPIEVAGERVWRTFRDIDSEHGAFDYSSAVPEGQDPFAVIVGSMLAAGIGREGFVGAARSRLFDAAPAVEFGVRWIEEHLNRDR	119.72	gnl|BL_ORD_ID|1395|hsp_num:0	1483		
BGC0000211.1|Chrysomycin_25 # 23186 # 23896 # 1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.665	BGC0000211.1|Chrysomycin_25 	23186	23896	+	Loose	400	24.6386	catA4	23.53	3004657	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGCCATTCATCACGCCCGACAACGGATCGCTCACCGTGTTCAACCTCTTCGACACCGTCGACAGGGACGGCCAGAAGACCCTGCTGGACACGATGGAGGGGATCATCAAGGGGGCGAACTACCCGGGGTGGCGCTCCTCCACCCTGCACGGCGGCCTCGACAAGCCCTGTGCCGCGAACTACATCCAGTGGCGCAGCGTGGACGATCTGCAGGAGCGCTACGAGGGTGAGAACTTCCGGCACAACACGGTGCCCTACTTCAAGGAACTGACCACCACGGTGCACCTGCTGAAGACCGAGGTGATCGCCACCCACCTGCATCCCGGGCTCGAGCGGATAGAGATCTCGCCGGAGCGGGACGACTTCACCGTCATCGTCGTCATGGGTGTCGAGCCCGAGAACCAGGCCACCCTCGTGGACCTGTTCGCGAAACCCGACTCCGCCATGGCGGACGTGCCGGGATACCGGTCCAACTCCATCCTGCGCGGCCTCGACGGTGACTTCGTCGTCAACTACGCCCAGTGGGACAGCCGCGAGGCGTACGAGACGTTCCACGGCCTGCCGGAGGACCGGCGTCCCGCGCACACCCGGGCCATGCGCGCGCAGGCGCGCCCGCTGCTGACGTCACGGTCGTCGAACACCTACGAGGTCGTGTTCGCGCGGTCCGCGAGCGACCAGCCGTCCACCGAGCAGCCGGCCGGTGACCGATGA	MPFITPDNGSLTVFNLFDTVDRDGQKTLLDTMEGIIKGANYPGWRSSTLHGGLDKPCAANYIQWRSVDDLQERYEGENFRHNTVPYFKELTTTVHLLKTEVIATHLHPGLERIEISPERDDFTVIVVMGVEPENQATLVDLFAKPDSAMADVPGYRSNSILRGLDGDFVVNYAQWDSREAYETFHGLPEDRRPAHTRAMRAQARPLLTSRSSNTYEVVFARSASDQPSTEQPAGDR	MDTKRVGILVVDLSQWGRKEHFEAFQSFAQCTFSQTVQLDITSLLKTVKQNGYKFYPTFIYIISLLVNKHAEFRMAMKDGELVIWDSVNPGYNIFHEQTETFSSLWSYYHKDINRFLKTYSEDIAQYGDDLAYFPKEFIENMFFVSANPWVSFTSFNLNMANINNFFAPVFTIGKYYTQGDKVLMPLAIQVHHAVCDGFHVGRLLNEIQQYCDEGCK	108.76	gnl|BL_ORD_ID|2253|hsp_num:0	3357		
BGC0000211.1|Chrysomycin_26 # 23893 # 26178 # 1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.734	BGC0000211.1|Chrysomycin_26 	23893	26178	+	Loose	550	32.3426	RlmA(II)	22.69	3001301	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGACCGTGCGCGCGGCGGACGACGGGGCGGTCCGCACCGCCCCCGGGCCGCCTCCCCTCCCCGGACCGGTCCGCGTCGGGCCGGACGACCCCCGCTACGGCGAACTGGTGCGCGGCGACAACCACCGCTTCACCGGCACGCCCGACCACGTCGAACTGGTCCGCTCCACCGAGCAGGCCGAGGACGCCCTCCGCCGGGCGCTGGCCGCCGGGCAGCGGGTCGCCGTGCGCAGCGGTGGCCACTGCCCGGAGGCGTTCGTGGCCGGCCCGGAGGTCGAGGTCGTCATCGACCTCTCCCTCATGTCGCGGGTCTCCTACGACCCGGAGCTCAACGCCGTCGCCATCGAGGCCGGGGCGACCGTCGGGCACGTGTACAAGGAGCTGTACCGGAACTGGAACGTGACCCTGCCGGCCGGTGTGTGCACCGCGGTCGGGGTCGGCGGCCACATCTCGGGCGGCGGGTACGGACCGCTGTCCCGGCTGCACGGCCTCGTCGCGGACCACCTCCACGCGGTCGAGGTCGTCCACGTCGACCGGTCCGGCCGGGTGCGCACCGTGATCGCCACCCGGGAGCCGGACGACCCCCACCGGGAGCTCTGGTGGGCCCACACCGGCGCGGGCGGCGGCAACTTCGGCATCGTCACCCGCTTCTGGATGCGTTCCCCCGGGGCGAGCGGCACCGACCCCGCCGGTCTGCTGCCCCGGCCGCCCGCCTCGCTGCTGACCGCGATGGTGAACTGGACGTGGGAGCAGTGCGAGCTGCCCGCGTTCACCCGGATCGTCCGCAACTTCATGGGCTGGCACGTCGCCAACAGCGCCCCCGGCTCGCCGTCCGCCGGGCTGTTCGCCTCGCTGTGGGTCAGACACCGCTCGGGCGGCGGGCTCACCATGTTCGTGCAGGCCGACGCCACGGAGCCGGACGCCGCGGCCGGGCTGGACGCGTTCCTCGCCGCCGTCGACGAGGGCGTCGGCGTCACCCCGTTCGTCCACCGCAGGGAACTGCCGTGGCTGACCGCCAGCCGGTACATGGGGCAGGGCGACTCCGGCCCCGTGATGGGGGCGCGGATCAAGACCAAGGCCGCCTATCTGCGGGACGTGCACACCGACGAGCAGATCGCCACCCTGTACCGGTGGTTCCACCGCGAGGACTACTTCGGCCGTGAGTCCCTGATGATGCTCAACGGCTACGGCGGCGCGATCAACGCGGTCGGACCGGCGGACACCGCGTCGGTCCAGCGGGACTCGGTGATCAAGGCGGCGTACTCGGCGTCCTGGGGCGACCCGGAGGAGGACGAGACGCACCTGACCTGGCTGCGCGGGCTCTACGGCGAGCTGTACGCCGGCACGGGCGGGGTGCCGGTGCCCGGCGGGCCGACGGACGGGTCGTACATCAACTACCCGGACATCGACCTCGCCGACCCGGACCACAACCGGTCGGGGGTGCCCTGGCACCAGCTCTACTACAAGGACAACTACGCGACGCTGCAGGCCGTCAAGGCGGCATGGGATCCCCGTGACGTCTTCCACCACGCCCTGTCCGTGCGGCTGCCGGAGGACGACATGACCTACCCCACCGCCCACATTCCCGAGCACTACGACTTCCGGGCCATCTACGCGGGCGAGAAGGACGCGTCGCCCGTCCAGCCGTGGGACATCGGCCGGCCGCAGCCCGCCCTGGTGGCCGCGCACGACGCGGGGGAGATCACCGGCGACGTCCTGGACGTCGGCTGCGGTCTCGGCGACAACGCCGCCTTCCTCGCCGGGCGGGGCCACCGGGTCACGGCGGTCGACGTGGCCGAGGCGGCCGTGCGGGAGGCGCGGCGTCGGGCAGAGGACAGTGGCGTCGACGTCGAGTTCGCCGTCGCGGACGCCACCCGGCTGACGGGGTACGACGGCCGCTTCGACACGGTCGTGGACAGCGCCTGCTTCCACTCGCTGTCCGAGGACGAACGGGAGCGGTACCTCCGCGCGCTGCGCACGGCGACCCGGCCGGGAGGCAGGCTGCACATGTTCTGCTTCGCCCAGGAGTTCGAGGCCCCGTTCCCGGGGCCGCACCGGCACACCGCAGCCTCCCTGCGCGAGATGGTCGGCGGTGTCTGGAACGTGCTCTCCGTGGAGGCCGCGACCTTCGCCAGCTCCCTCGGCGTCGAGGACATCGCCGCCCTGATCGAGTCGGAGTACCCGGACGGCGACGTCGACCCGGCCCGGCTCGACGGGCTCCCGCTCGACGAGCACGGCAAGGCCACGATGCCGGTCTGGCACGTGACCGCGGAACGCCGCGACTGA	MTVRAADDGAVRTAPGPPPLPGPVRVGPDDPRYGELVRGDNHRFTGTPDHVELVRSTEQAEDALRRALAAGQRVAVRSGGHCPEAFVAGPEVEVVIDLSLMSRVSYDPELNAVAIEAGATVGHVYKELYRNWNVTLPAGVCTAVGVGGHISGGGYGPLSRLHGLVADHLHAVEVVHVDRSGRVRTVIATREPDDPHRELWWAHTGAGGGNFGIVTRFWMRSPGASGTDPAGLLPRPPASLLTAMVNWTWEQCELPAFTRIVRNFMGWHVANSAPGSPSAGLFASLWVRHRSGGGLTMFVQADATEPDAAAGLDAFLAAVDEGVGVTPFVHRRELPWLTASRYMGQGDSGPVMGARIKTKAAYLRDVHTDEQIATLYRWFHREDYFGRESLMMLNGYGGAINAVGPADTASVQRDSVIKAAYSASWGDPEEDETHLTWLRGLYGELYAGTGGVPVPGGPTDGSYINYPDIDLADPDHNRSGVPWHQLYYKDNYATLQAVKAAWDPRDVFHHALSVRLPEDDMTYPTAHIPEHYDFRAIYAGEKDASPVQPWDIGRPQPALVAAHDAGEITGDVLDVGCGLGDNAAFLAGRGHRVTAVDVAEAAVREARRRAEDSGVDVEFAVADATRLTGYDGRFDTVVDSACFHSLSEDERERYLRALRTATRPGGRLHMFCFAQEFEAPFPGPHRHTAASLREMVGGVWNVLSVEAATFASSLGVEDIAALIESEYPDGDVDPARLDGLPLDEHGKATMPVWHVTAERRD	MNTNLKPKLQRFASATAFACPICQENLTLLETNFKCCNRHSFDLAKFGYVNLAPQIKQSANYNKENFQNRQQILEAGFYQAILDAVSDLLASSKTTTTILDIGCGEGFYSRKLQESHSEKTFYAFDISKDSVQIAAKSEPNWAVNWFVGDLARLPIKDANMDILLDIFSPANYGEFRRVLSKDGILIKVIPTENHLKEIRQRVQDQLTNKEYSNQDIKEHFQEHFTILSSQTASLTKTITAEQLQALLSMTPLLFHVDQSKIDWSQLTEITIEAEILVGKAF	269.86	gnl|BL_ORD_ID|2104|hsp_num:0	2274		
BGC0000211.1|Chrysomycin_27 # 26213 # 27199 # 1 # ID=1_27;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.778	BGC0000211.1|Chrysomycin_27 	26213	27199	+	Loose	1200	30.8018	arnA	34.04	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	GTGGGGCTCCGCGCGTCCCCGCACCCCACCCCCTCACCGACCCCCCGGAGTCGCCGGAATGCCGACAACTCCGCGGCGGTGGGTCGTCCTGGGCGCCGAGGCCTGCTGGGCTCCGCCTCGCCGACGTCGCCTCCGCCGACCCCCGGGTCGCCGTCCACCGGGCGGGACGGCCCGGCCGACATCACCCGCGCCGCCGGGACCGAACGGCTGATGCGCGCCGTACGGCCGGACGTCGTCGTCAACGCCGCCGTGTTCACCGGCGTGGACCCCTGCGAGGCCGACCCGGCGCGCGCGTACGAGGTCAACGCCGTCGGCGCGCGCCATGTGGCGCGGGCCTGCGCCGACGTCGGCGCCCGCTGCGTCTACATCAGTACCGACTACGTCTTCGACGGCACCGCACCAGACCCCTACGACGAGACGGCACCGCCCCGCCCCCTGCTGACGTACGGCATGTCCAAGCTCGCCGGGGAGGGCGAGACCCTGAACGCGAGCCCCGGACACCTGGTGGTGCGCACCGCCGCTCTGTTCGGGCCGCCGCCGCCGAGCCACCGGCGCCGGCCGGGATTCGTCGAGCAGATCCTGCGCCGCGCGGCGGCCGGACAGCGCGCCGACGTGACCGACGCCCTGGTCATGTCCCCCACGTACACGGCCGACCTGGCCCGCATGGTCGTCGAACTGCTCGCCGCCGATGCGGACGGCGGGCCCTACCACGTGACCAACGAGGGCAGCGCCACCTGGTACGGCCTCGCGCACGCCGCCGTCTCCGGCCTGGGACTCGGCGCCCTGCCCCGGCAGGCCGCGCCCGGCGCCGGTGCGGCCGGTCCCGCGCGGCCCGCCGCCACGCCCCTGACCTCCGTGCGGCTGCCGCCGCGCGTGCGGCGGCTCAACCGCCCCTGGCGCGACGCCCTCGCGGAGTTCCTGCGCGACCACGGACCGGACGCCCTGGCCGCGGCCCGGCCCGGGCCTCCCCTTCCCGACGCCCCGTGA	MGLRASPHPTPSPTPRSRRNADNSAAVGRPGRRGLLGSASPTSPPPTPGSPSTGRDGPADITRAAGTERLMRAVRPDVVVNAAVFTGVDPCEADPARAYEVNAVGARHVARACADVGARCVYISTDYVFDGTAPDPYDETAPPRPLLTYGMSKLAGEGETLNASPGHLVVRTAALFGPPPPSHRRRPGFVEQILRRAAAGQRADVTDALVMSPTYTADLARMVVELLAADADGGPYHVTNEGSATWYGLAHAAVSGLGLGALPRQAAPGAGAAGPARPAATPLTSVRLPPRVRRLNRPWRDALAEFLRDHGPDALAAARPGPPLPDAP	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	49.55	gnl|BL_ORD_ID|1549|hsp_num:0	1643		
BGC0000211.1|Chrysomycin_28 # 27217 # 28452 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.687	BGC0000211.1|Chrysomycin_28 	27217	28452	+	Loose	2200	25.0238	rpoB2	30.3	3000501	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	ATGTCCGACCTGCCGAACTGCCGTATCTGCGGCGGTGCCCTGCGCGAGTTCCTCGACCTGGGGGAACAGCCCATGGGCAACGCCTTCGTGACTCCCGGGCGACAGGACGACGAGGCCGGTGCCTTCCGTTTCCGGCTCACGGTCGCCGTGTGCGAGGTGTGCACCATGGTGCAGCTCACCGACTACGTGCGGCACGACCGGATGTTCCACGCCGCCTATCCCTACCGTTCCTCGCAGTCGTCCGTCATGAGCGCCCACTTCGAGAACCTGGCGCGGCGCTTCCTCCAGGACGAGCTGAACGGCACCGACCCGTTCATCGTCGAACTCGGCAGCAACGACGGCATCATGCTGCGCACCGTCGCCAAGGCGGGGGTGCGCCACCTGGGCGTCGAGCCGTGCGGGGACGTCGCCGAGGTCGGACGCGCGAACGGTGTCCGCGTGGTCAGCGAGTTCTTCGACGAGGACCTCGCCGCCCGGATCCGCGCCGCCGACGGCACGGCGGACGTCGTCTTCGCCGCGAACACGTTCTCGCACATCGACTTCCTGGACTCCATCCTGCGCGGCGTCAAGAACCTGCTCGCCCCCGGCGGCGTCTTCGTCTTCGAGGACCCGTACTTCGGCGACATCGTGCAACGCGCCTCGTTCGACCAGATCTACGACGAGCACATCTTCTTCTTCACGGCACGTTCCGTCCAGGACATGGCCGCCCGTCACGGCCTCGAACTCGTCGACGTGGAACTGCTGCCGGTGCACGGCGGCGAGTTGCGGTGCACCCTCGCCCACACCGGCGCACGTCCCGTCAGCCCCGCGGTGCCGCGGCTGCTGAGGCAGGAGGAGGAGCAGGGTCTCACCGAGACCGCGACGCTGACCCGCTTCGCGGACGGCGTGCGGGAGCTCGGCGAGACCCTGGTGACCCGGCTGCGCGAACTGCGGGACCAGGGCAAGCGCGTGGTCGGCTACGGGGCCACCGCCAAGAGCACCACCCTGCTCAACTACTGCGGGATCGGCCCGGACCTGGTCTCCTTCGTCTGCGACTCCACCGCCGAGAAACAGGGGCGGCTCACCCCGGGCACCCATATCCCCGTCCGGAGCTCGGAGGCCTTCGCTGACCCCTACCCCGACTACGCGCTCCTGCTGGCCTGGAACCACAAGGACGAGATCCTCGACAAGGAGTCCGCGTTCCGCGAGGCGGGCGGGCGATGGATCCACTACGTGCCGGACGTGCACATCGACTGA	MSDLPNCRICGGALREFLDLGEQPMGNAFVTPGRQDDEAGAFRFRLTVAVCEVCTMVQLTDYVRHDRMFHAAYPYRSSQSSVMSAHFENLARRFLQDELNGTDPFIVELGSNDGIMLRTVAKAGVRHLGVEPCGDVAEVGRANGVRVVSEFFDEDLAARIRAADGTADVVFAANTFSHIDFLDSILRGVKNLLAPGGVFVFEDPYFGDIVQRASFDQIYDEHIFFFTARSVQDMAARHGLELVDVELLPVHGGELRCTLAHTGARPVSPAVPRLLRQEEEQGLTETATLTRFADGVRELGETLVTRLRELRDQGKRVVGYGATAKSTTLLNYCGIGPDLVSFVCDSTAEKQGRLTPGTHIPVRSSEAFADPYPDYALLLAWNHKDEILDKESAFREAGGRWIHYVPDVHID	MLEGRIVTVSSRTESPLAAPGVPGAPRRLSFARIREPLAVPGLLDIQTESFGWLIGAPDWCARAAARGTEPVAGLAEVLAEISPIEDFAGTMSLTLSDPRFEEVKASVEECKDKDLTYAAPWFVTAEFVNNNTGEIKSQTVFMGDFPMMTAHGTFVVNGTERVVVSQLVRSPGVYFDHAIDKGSEKDVHSARVIPSRGAWLEFDVDKRDTLGVRIDRKRRQPVTVLLKALGWSAERIAERFGFAPLIMASLAKDNVAGTDDALLEIHRKLRPGEPPTKESAQNLLANLFFTEKRYDLARVGRYKIDKKLGLRAPGAPRVLTEDDIAATIEYLVRLHAGERTMIAPGGVEVPVEVDDIDHFGNRRVRTVGELIQNQIRVGLSRMERVVRERMTTQDVEAITPQSLMNIRPVVAAMKEFFGTSQLSQFMDQRNPLASLTNKRRLSALGPGGLSRERAGLEVRDVHYSHYGRMCPIETPEGPNIGLMGYLSVYARVNPFGFVETPYRRVVDGRVTDEVDYLTADEEDRHVVAQANEPLDAEGRFLAARIPVRRKNSEVELVDSAAVDYMDVSPRQMVSVATAMIPFLEHDDANRALMGANMQRQAVPLIRSEAPIVGTGMELRAAVDAGDVVVNEKAGVVEEVSADYVTVMADDGTRKSYRMRKFNRSNQGTCSNQRPIVDEGQRVEAGQVLADGPCTENGEMALGKNLLVAIMPWEGHNYEDAIILSQRLVEQDVLTSIHIEEHEIDARDTKLGAEEITRDIPNVSDEVLADLDERGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGESGKVIGIRVFSREDDDDLPPGVNELVRVYVAQKRKIQDGDKLAGRHGNKGVIGKILPTEDMPFLPDGTPVDIILNTHGVPRRMNIGQILETHLGWIGKAGWKVEGNPEWAKDLPEEMWEAPADSNIATPVFDGAREEELTGLLGSTLPNRDGERMVDDNGKAVLFDGRSGEPFPYPVAVGYMYILKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDVVGRVKVYEAIVKGDNIPEPGVPESFKVLLKELQALCLNVEVLSAGAAVELAHGVDDDHERTAANLGINLSRAESITETELSG	35.37	gnl|BL_ORD_ID|2485|hsp_num:0	2831		
BGC0000211.1|Chrysomycin_29 # 28508 # 29446 # 1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.739	BGC0000211.1|Chrysomycin_29 	28508	29446	+	Loose	400	26.5646	ErmV	53.12	3002824	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGCCTGAGATGCGCTTCGTCGTCACGGGCTCCATCGCGACCGACCATCTGATGACCTTCCCCGGCCGTATCGGCGAACAGCTGATCGCCGGCAAGCTGGACCGCATCTCCCTCTCGCTGCTCGTCGACGACCTGGAGGTCCGGGACGGCGGTGTGGCCGCCAACATCGCCTACGGCCTGGCCCGGCTCGGTCACCGTCCGCTCCTCGTCGGGGCGGTCGGAACCGACTTCCACGACTACGGCGCCCGCCTGGCCGCCCTCGGGGTGGACACCTCGGCCGTCCGGGTCTCCACCACCCGGCACACGGCCCGCTTCCTGTGCACCACCGACACCGACGGCGGCCAGCTGGCCACCTTCTACGCCGGAGCGATGGCCGAGGCGTCCACGATCGACCTCGGCGACGTGCTGCGCCGCCACGGGGGCGCCGACCTCGTGCTGATCGGCGCCGACGACCCCACGGCGATGGCCCGCCACACCAGGGCCTGCCGCGCCCTCGGCGTCCCCTTCGCCGCAGACCCGGCGCAGCAACTGGCCCGGCTCACCGGCCCGGAGATCAGGGAACTGGTCGAGGGAGCGGACCATCTGTTCACCAACGAGTACGAGCGCGAGCTGCTGCTGGGCAAGACGGGCTGGACGCCGCAGGACGTGCTGCGCAGGACCGGCGTCTGGATCACCACGCTCGGCGACGAGGGCAGCCGCGTCGAGCGGGCCGGCGAACCTCCGGTGGGGGTCCCGGCCGTCCCGGCCCGCACGGTCGCCGACCCGACCGGAGTCGGTGACGCCTTCCGCGCCGGCTACCTGGCCTCCCTCGCGGCGGGCGCCGATGTGGAGCGGTGCGCACGGGCCGGGTCCGCTCTGGCCACCCTGGCGCTGTCGGCCGTCGGCACCCAGACGTACGTGCCCGCCCCCGCTCACCTCCACGAGCCGCCGCCGCGGTGA	MPEMRFVVTGSIATDHLMTFPGRIGEQLIAGKLDRISLSLLVDDLEVRDGGVAANIAYGLARLGHRPLLVGAVGTDFHDYGARLAALGVDTSAVRVSTTRHTARFLCTTDTDGGQLATFYAGAMAEASTIDLGDVLRRHGGADLVLIGADDPTAMARHTRACRALGVPFAADPAQQLARLTGPEIRELVEGADHLFTNEYERELLLGKTGWTPQDVLRRTGVWITTLGDEGSRVERAGEPPVGVPAVPARTVADPTGVGDAFRAGYLASLAAGADVERCARAGSALATLALSAVGTQTYVPAPAHLHEPPPR	MARPSRVSRALSQNFLADRAAAGQLARLAAPHGLPVPLLLEVGAGKGALTELLAPRCRSLLAYEIDPRLVPVLRSRFADAPHVRVLGEDFLRARAPRTPFSVAGNVPFSRTAAVVAWCLRAPHLTDATLLTQLEYARRRTGDYGSWTRLTVLTWPRHEWRLAGRVGRRSFRPVPRVDAGIVRIERRRTPLLAPGADAGWRELVDLGFSGAGGSLHASLRRARPRRRVDAAFRAAGLDRDVLVGEVPPWTWLRLHEVLGS	120.46	gnl|BL_ORD_ID|1121|hsp_num:0	1188		
BGC0000211.1|Chrysomycin_30 # 29597 # 30229 # -1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.733	BGC0000211.1|Chrysomycin_30 	29597	30229	-	Loose	800	26.1794	tetA(P)	31.48	3000180	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAGACTCACCGTGTTCGGTGCCACGGGAGGCATCGGCCAGGAGATCGTCCGGCAGGCGCTGGACGCGGGACATCACGTCACGGCGGTCGTCCGGAACCCCGCTGGGCTGACCGTCACCGGTACGCAGCTGGAGGTGTTCCGCGCCGACCTGACCGATCCGGAGGCGGTGCGCCCCGCGGTGGCCGGACGGGACGCCGTGCTGTCCGGCCTCGGCGCCCGCAGCCGCAAGGACGCCGGCGTCGCGACCCGGCTCACACGTACGGTGCTGCGCGCCATGGAGGCGGAGGGCACACGGCGTCTCCTGGTCGTGAGCGCGGCTCCGGTCGGCCCCGGGGCGGAAGGCGACGGACCGCTCGACCGTGCCCTGCGCGGCATCGTCTCCGCCGTCCTCAAGGACATCTACGCCGATCTGCGAGAGATGGAGGCCGAGCTGACCCGGAGCGCCACGGACTGGACGGCCGTACGGCCGCCGCGCCTGCAGAACAAGCCCGTCAGCGGCAGGTACCGGACGGTCGTCGGCGGTACGCCGCCCCGGGGCCGTCTCATCGGCCGCGCGGACGTCGCCCACGCCATGCTCGCGATGACCGACGACCTCGGGACGGTGAAGCAGGGGGTGGGGATCGCGTACTAG	MRLTVFGATGGIGQEIVRQALDAGHHVTAVVRNPAGLTVTGTQLEVFRADLTDPEAVRPAVAGRDAVLSGLGARSRKDAGVATRLTRTVLRAMEAEGTRRLLVVSAAPVGPGAEGDGPLDRALRGIVSAVLKDIYADLREMEAELTRSATDWTAVRPPRLQNKPVSGRYRTVVGGTPPRGRLIGRADVAHAMLAMTDDLGTVKQGVGIAY	MVNKLSAYKTYLLFSAITAMCFSLVATVMMVYHIEIVHLNPLQLILVGTTLELACFIFEIPTAIVADVYSRKLSIVIGGVLTGVGFILEGSISSFVFVLVAQIVWGLGSTFISGSLEAWIAEEEKNKDLDEIYIKGAQAGQIGAFIGIVLSTVIANFSVRLPIIVSGVLFIILALFLWLYMPENNFKPSAPGDLNTFKKMVYTFKSGLKFVKSKSIIMILLAVTLFYGLSSEGYDRLSNAHFLQDTTLPKLGNLSSVTWFGIFGILGMILSFIVMHFMAKNLKNEDNRKNGKLLLCINILYISSMLIFALTRNFSLMLIAYLATNTFRIINKPIFSAWLNGHIDDNSRATVLSINGQMNSLGQILGGPIIGIIATNISVSIGIVCTSLLVTPVLVLYIVAMIIDKKVDDRVGGIDYEENN	50.00	gnl|BL_ORD_ID|477|hsp_num:0	508		
BGC0000211.1|Chrysomycin_31 # 30344 # 30958 # 1 # ID=1_31;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.730	BGC0000211.1|Chrysomycin_31 	30344	30958	+	Loose	375	41.9726	nalD	44.44	3000819	protein overexpression model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGAATCCCCGGGGAGCACGCGGCACAGGCCGGCCGAGGCCCGGATCCTCGACGCCGCCTACGAGCTCATGCGCACGGTGGGACTGGCCCGCACCACGACCAAGGAGATCGCCCGGGCGGCCGGTTGCTCGGAGGCCGCGCTGTACAAGTACTTCGCGGGCAAGGAGGAGCTGTTCATCCGCGTGCTGGCCGAGAGGCTGCCGCGGCTCACCCCGCTGCTGCGCAGTCTCGCCGCCGAGCCCGGGCGAGGGACGCTGGAGGACAACCTCACCGAGATCGCCCGTCAGGCCGCGCTCTTCTACGAGCAGAGCTTCCCGATCGCCGCGTCCCTCCACGCCGAGACCCAGCTCAAGCGACGGCACGACGACGCGATGCGGCGGATGGGGTCCGGACCGCATCTGCCCATCCGGGAACTCGACGCCTACCTGCGCGCCGAGCAGGAGCTGGGGCGGATCGGCACCGAAGCGGACACGTTCGCGGCGGCGTCCCTGCTGATGGGCGCCTGCGCGCAACGGGCGTTCGCCTACGACGCGGCCCAGGAGGGTGCGCGCCCCCCGGTGGACGACTTCGCCGCCCGCCTGGCCCGTACCCTGCTGGCCGGCCTGGCCGGCTGA	MESPGSTRHRPAEARILDAAYELMRTVGLARTTTKEIARAAGCSEAALYKYFAGKEELFIRVLAERLPRLTPLLRSLAAEPGRGTLEDNLTEIARQAALFYEQSFPIAASLHAETQLKRRHDDAMRRMGSGPHLPIRELDAYLRAEQELGRIGTEADTFAAASLLMGACAQRAFAYDAAQEGARPPVDDFAARLARTLLAGLAG	MRRTKEDSEKTRTAILLAAEELFLEKGVSHTSLEQIARAAGVTRGAVYWHFQNKAHLFNEMLNQVRLPPEQLTERLSGCDGSDPLRSLYDLCLEAVQSLLTQEKKRRILTILMQRCEFTEELREAQERNNAFVQMFIELCEQLFARDECRVRLHPGMTPRIASRALHALILGLFNDWLRDPRLFDPDTDAEHLLEPMFRGLVRDWGQASSAP	96.23	gnl|BL_ORD_ID|2397|hsp_num:0	1213		
BGC0000211.1|Chrysomycin_32 # 30996 # 31403 # -1 # ID=1_32;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.637	BGC0000211.1|Chrysomycin_32 	30996	31403	-	Loose	800	26.1794	lmrP	35.0	3003969	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCGGACGAACATCATCCGGCACGAGAACATGATGGCCAGCTACGACATGGTGAACGGCTGGACCGTCGTCGAGATCGACGGTGACATGGACGGCCACACCTCGCCGATGATCCGTGATGCACTGATCGAGCTCATCGACGAGGGACACCGTCACTTCATCCTCGATCTCAACTTCGTTCCCTTCCTGGATTCCATGGGCCTGGGCATGATCGTGGCGGTCACGAAGCGCATCCGGGGACGCGACGGCTCGCTGCGCATCGTGTCCGCCTCCAGCCGGGTGCTCCGGATCTTCGACCTCAGCGGCATGCGCCAGAGTTACGAGGTCTACCACTCCCGGGAGGAGGCGACGCGTACCGCTCCCACACTCGGCGGTCTCGTGCACTGGCCGCACGCGGTGTCCGGCTGA	MRTNIIRHENMMASYDMVNGWTVVEIDGDMDGHTSPMIRDALIELIDEGHRHFILDLNFVPFLDSMGLGMIVAVTKRIRGRDGSLRIVSASSRVLRIFDLSGMRQSYEVYHSREEATRTAPTLGGLVHWPHAVSG	MQEFLNLPKQIQLRQLVRFVTITLGSSIFPFMAMYYTTYFGTFWTGLLMMITSLMGFVGTLYGGHLSDALGRKKVIMIGSVGTTLGWFLTILANLPNAAIPWLTFAGILLVEIASSFYGPAYEAMLIDLTDESNRRFVYTINYWFINIAVMFGAGLSGLFYDHHFLALLVALLLVNVLCFGVAYYYFDETRPETHAFDHGKGLLASFQNYRQVFQDRAFVLFTLGAIFSGSIWMQMDNYVPVHLKLYFQPTAVLGFQVTSSKMLSLMVLTNTLLIVLFMTVVNKLTEKWKLLPQLVVGSLLFTLGMLLAFTFTQFYAIWLSVVLLTFGEMINVPASQVLRADMMDHSQIGSYTGFVSMAQPLGAILASLLVSVSHFTGPLGVQCLFVVIALLGIYFTVVSAKMKKV	33.25	gnl|BL_ORD_ID|2250|hsp_num:0	2435		
BGC0000211.1|Chrysomycin_33 # 31466 # 31828 # -1 # ID=1_33;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.705	BGC0000211.1|Chrysomycin_33 	31466	31828	-	Loose	1200	22.7126	tetO	35.9	3000190	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGGTCGGACAGATCGCCTGCCGCAGGGTCTACGAGGAGACCTCACCGCAGGAGGGCAAGCGCGTCCTCGTGGACCGGGTCTGGCCCCGGGGCATGCGCAAGGAGGACGCGCGTCTCGACGAGTGGCTGCGTGACGTCGCCCCGTCGAGCGAACTGCGAAAGTGGTACGGCCACGAGCCGAGCCGCTTCACCGAGTTCCGCCGTCGCTACCTCGAGGAGCTGCGCGACGCCGGGCACCGCGAGGCGGCCGGGCATCTGCACGACCTGGCGGAGCACGACGGGCTCGTGCTGCTGACCGCCACCAAGGATGTGGACCACAGCCAGGCCGCCGTCCTGGCCGAATGGCTGGCGGGGAAGGGGTGA	MVGQIACRRVYEETSPQEGKRVLVDRVWPRGMRKEDARLDEWLRDVAPSSELRKWYGHEPSRFTEFRRRYLEELRDAGHREAAGHLHDLAEHDGLVLLTATKDVDHSQAAVLAEWLAGKG	MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAVTSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMKIPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIMGNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGTRQLIEVIASKFYSSTPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMYVPTNGELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMIQTTIAVKKSEQREILLGALTEISDCDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIYMERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEGVLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQGVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA	18.78	gnl|BL_ORD_ID|1905|hsp_num:0	2020		
BGC0000211.1|Chrysomycin_34 # 32381 # 32989 # 1 # ID=1_34;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.759	BGC0000211.1|Chrysomycin_34 	32381	32989	+	Loose	380	39.6614	AcrS	29.69	3000656	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCCTACCGCAAGACCCCCGCCGAGATCAGCCGTCTCGAAGCCGCGCGAGAGCGCCTCGTCGTCTGCGCCACGTCCGTGGTGGCGGAAGTCGGCTGGGCCCAGGCGTCCGTGACCGCCGTCGCGGACGCGGCCGGCATCGCGGCGGGCTCCGTCTACCAGCACTTCCCCTCCAAGGCGGCACTCGCCGTCGAGGTGTTCCGACGCGCGGCCGGACGCGAGGTCGACGTGCTCGGCGAGGTACTGCACGGCCCCGGCGGCCCCGTCGGGCGACTCGCCCGCGGCGCCCAGGTCTTCGCCCGCCGTGCCCTGGAGAACCGGGGCCTGGCCTACGCGCTGCTCGCGGCCCCCGCCGAACCCGCGGTGGGCGCCGAGCGTCTCGACTTCCGGCGCCGCTACCGCGCGCTGTTCGCCGAGGTGGTCCGCGAGGGAGTGGCCGCAGGCGTACTGCCCGAGCAGAACGCCGAGATCACCGCCGCCGCCCTCACCGGCGCGATCGGCGAAGTACTGGTGGACCCGCTCGCCGCCCCGGACGAAGGCTCCATCGAGGCGCTGCTCACCGACCTCACCGCCACCGCGCTGCGCTGCGCGGGCGCACCGGCCGCCTGA	MAYRKTPAEISRLEAARERLVVCATSVVAEVGWAQASVTAVADAAGIAAGSVYQHFPSKAALAVEVFRRAAGREVDVLGEVLHGPGGPVGRLARGAQVFARRALENRGLAYALLAAPAEPAVGAERLDFRRRYRALFAEVVREGVAAGVLPEQNAEITAAALTGAIGEVLVDPLAAPDEGSIEALLTDLTATALRCAGAPAA	MAKRTKAEALKTRQELIETAIAQFAQHGVSKTTLNDIADAANVTRGAIYWHFENKTQLFNEMWLQQPSLRELIQEHLTAGLEHDPFQQLREKLIVGLQYIAKIPRQQALLKILYHKCEFNDEMLAEGVIREKMGFNPQTLREVLQACQQQGCVANNLDLDVVMIIIDGAFSGIVQNWLMNMAGYDLYKQAPALVDNVLRMFMPDENITKLIHQTNELSVM	91.82	gnl|BL_ORD_ID|488|hsp_num:0	520		
BGC0000211.1|Chrysomycin_35 # 33017 # 34654 # 1 # ID=1_35;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.737	BGC0000211.1|Chrysomycin_35 	33017	34654	+	Loose	890	27.7202	OprA	30.34	3003039	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCCACGACCGGCCTCGTCACCCACGAAGTGACCAACCAGCCACCGCCGTTGACCGGCCACGACACCGCGGACGACCCGGTCCTCCTCGAAGGAGTACACCGAGAGGGAGCCGCCTGGCATCTGGACGACCTGCACCGGCTGGGCCGCCTGGCCGGAAGCGAGGAGGCCCAGGGCTGGGCGGACCAGGCCAACCGGCACGAGCCCGAGCTGCGCACCCACGACCGCTACGGGCACCGCGTCGACGAGGTCGACTTCCACCCCGCCTACCACTCGCTGATGGACGTCTCGGTGAGCGCCGGCATCGCGGGCGCCGCCTGGACCGACGAGCGGCCCGGCGCCCACGTGGCACGGGCGGCGAGCTTCATGCTGGCCACCATGCTGGAGCCGGGCCATCTGTGCCCGGTCTCCATGACGTACGCCGTCGTCCCCGCGCTGCGCCACGCCCCCGACCTCGCCAAGACCTACGAGCCCCTGCTCACCAGCCGCGTCTACGATCCCGGACTGCGCGTCCCCGCCGGCAAGCGCGGTCTGCTCGCCGGTATGGGCATGACGGAGAAGCAGGGCGGCACCGACGTCCGCGCCAACACCACCGCCGCCACCGAACAGGCCGACGGGAGGTGGCGGCTGCGCGGCCACAAGTGGTTCACCAGCGCCCCGATGAACGACCTGTTCCTCGTGCTCGCCCAGGCGCCCGGCGGGCTGTCCTGCTTCCTGGTCCCGCGCGTCCTGCCGGACGGCAGCCGCAACACGTTCCGCATCCAGCGCCTCAAGGACAAGCTCGGCAACCGCTCCAACGCCAGCAGTGAACCCGAGTTCGACGACACCGTGGCCTGGCTCGTCGGCGACGAGGGCAAGGGCGTGCGGACCATCATCGACATGGTGACCATGACGCGGCTCGACTGCGTCCTCGGCTCCGCCGCCGGCACCCGGGCCGCGCTCGCGCAGGCAGCCCACCACGCCCGGCACCGCTCGGTGTTCGGCGCCGAGCTGATCGACCAGCCCCTCATGCGCAACGTCCTGGCCGACCTCGCGCTGGAATCCGAGGCCGCCACGACCCTGGCGCTGCGGCTGGCCGGTGCCGCCGACCGGGCCCAGCGCGGGGACGCGGGGGAGCGGGCCTTCCTGCGCCTGGCCACCGCCGTCGGCAAGTACTGGGTCTGCAAGCGCCAGCCCGCCGCCGTGGCCGAGGCCCTCGAGTGCCTGGGCGGCAACGGCTACGACGAGGCGTCCGGGATGCCGCGCCTCTACCGCGAGGCGCCGCTCAACGGCATCTGGGAGGGCTCCGGCAACGTCAACGCCCTCGACATGCTCAGGGCGTTGACGCGCGAACCGGAATCCCTGGAGGCCTACCGCGCGGAGGTGGAGCCGGCGGCCGGGGCGGACCGCCGCCTGGACGCCGCCTGGCGGGAACTCCAGGGAGAGCTCGTCCTCACCGAGGACGCCTCCCTTCGTGCCCGCCGGGTCATCGAGCGCGCGGCCCTCGTGCTGCAGGGCTCGCTCCTGGTCCGGCACGCGCCCGCGCCGGTCGCGGACGCGTTCTGCGCGTCGCGCCTCGCCGGCGACCGGGGCCTCGCCTTCGGAACCCTGGCGCCCGGCACGGACTTCGCGGGTCTGCTGGGGCGGCTTCCCGTGTGA	MPTTGLVTHEVTNQPPPLTGHDTADDPVLLEGVHREGAAWHLDDLHRLGRLAGSEEAQGWADQANRHEPELRTHDRYGHRVDEVDFHPAYHSLMDVSVSAGIAGAAWTDERPGAHVARAASFMLATMLEPGHLCPVSMTYAVVPALRHAPDLAKTYEPLLTSRVYDPGLRVPAGKRGLLAGMGMTEKQGGTDVRANTTAATEQADGRWRLRGHKWFTSAPMNDLFLVLAQAPGGLSCFLVPRVLPDGSRNTFRIQRLKDKLGNRSNASSEPEFDDTVAWLVGDEGKGVRTIIDMVTMTRLDCVLGSAAGTRAALAQAAHHARHRSVFGAELIDQPLMRNVLADLALESEAATTLALRLAGAADRAQRGDAGERAFLRLATAVGKYWVCKRQPAAVAEALECLGGNGYDEASGMPRLYREAPLNGIWEGSGNVNALDMLRALTREPESLEAYRAEVEPAAGADRRLDAAWRELQGELVLTEDASLRARRVIERAALVLQGSLLVRHAPAPVADAFCASRLAGDRGLAFGTLAPGTDFAGLLGRLPV	MPLSKLSASSLALCLGLLGACSLAPRYQRPEAPIPTTYPAVPASQQAGDRARLDDWQQQFTDPVLRQMIGQALEHNRNLRVAALRIEEARALYGVQASERLPTLEASGRYERERMRGETREAGEVEQRYRVAAGISAFELDFFGRVKNLGDAALADYLASEEAQRSARIALIAEVAGGYVQERALYAQQRLAERTLHARENGLALVRKRYAAGMSTRIDLRSEEMLVESARATHAALVRERSQAVSGLQLLLGDFTGDWQDSQLDLEHLQLQPLPAGLPSELLARRPDIRQAEQQLRAANANIGAARAAFFPSLRLSTDLGSASSGLHGLFRGGSRVWTFSPQMTLPIFDGGRNRANLDLAEVRKDIAVNRYEESIQVAFREVADALSAGDQLELQLRAQRAVRDADRERLQLVRKRYAKGVANYLEMLDAQRSLFDSEQQLIHLRGLRLNNGVALYRALGGGWSQG	116.70	gnl|BL_ORD_ID|1476|hsp_num:0	1570		
